{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T18:30:38Z","timestamp":1785695438694,"version":"3.56.0"},"reference-count":294,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NRF","award":["NRF-2018R1A5A2023127"],"award-info":[{"award-number":["NRF-2018R1A5A2023127"]}]},{"name":"NRF","award":["BK21 FOUR program"],"award-info":[{"award-number":["BK21 FOUR program"]}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","award":["NRF-2020R1A2C3004973"],"award-info":[{"award-number":["NRF-2020R1A2C3004973"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","award":["NRF-2020M3E5E2038356"],"award-info":[{"award-number":["NRF-2020M3E5E2038356"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HP20C0131"],"award-info":[{"award-number":["HP20C0131"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s12272-022-01410-5","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T09:02:41Z","timestamp":1667293361000},"page":"761-794","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mouse models of nonalcoholic steatohepatitis and their application to new drug development"],"prefix":"10.1007","volume":"45","author":[{"given":"Hieu Huy","family":"Phung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2210-0793","authenticated-orcid":false,"given":"Chang Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"1410_CR1","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/hep.25741","volume":"56","author":"MF Abdelmalek","year":"2012","unstructured":"Abdelmalek MF, Lazo M, Horska A, Bonekamp S, Lipkin EW, Balasubramanyam A, Bantle JP, Johnson RJ, Diehl AM, Clark JM, Subgroup FL, of Look, A. R. G. (2012) Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology 56:952\u2013960. https:\/\/doi.org\/10.1002\/hep.25741","journal-title":"Hepatology"},{"key":"1410_CR2","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/hep.23535","volume":"51","author":"Abdelmalek, M. F., Suzuki, A., Guy, C., Unalp-Arida, A., Colvin, R., Johnson, R. J., Diehl, A. M., and Nonalcoholic Steatohepatitis Clinical Research, N","year":"2010","unstructured":"Abdelmalek, M. F., Suzuki, A., Guy, C., Unalp-Arida, A., Colvin, R., Johnson, R. J., Diehl, A. M., and Nonalcoholic Steatohepatitis Clinical Research, N (2010) Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51:1961\u20131971. https:\/\/doi.org\/10.1002\/hep.23535","journal-title":"Hepatology"},{"key":"1410_CR3","doi-asserted-by":"publisher","first-page":"5033","DOI":"10.1093\/nar\/gkv331","volume":"43","author":"T Adhikary","year":"2015","unstructured":"Adhikary T, Wortmann A, Schumann T, Finkernagel F, Lieber S, Roth K, Toth PM, Diederich WE, Nist A, Stiewe T, Kleinesudeik L, Reinartz S, M\u00fcller-Br\u00fcsselbach S, M\u00fcller R (2015) The transcriptional PPAR\u03b2\/\u03b4 network in human macrophages defines a unique agonist-induced activation state. Nucleic Acids Res 43:5033\u20135051. https:\/\/doi.org\/10.1093\/nar\/gkv331","journal-title":"Nucleic Acids Res"},{"key":"1410_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1042\/CS20140732","volume":"129","author":"MB Afonso","year":"2015","unstructured":"Afonso MB, Rodrigues PM, Carvalho T, Caridade M, Borralho P, Cortez-Pinto H, Castro RE, Rodrigues CM (2015) Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis. Clin Sci 129:721\u2013739. https:\/\/doi.org\/10.1042\/CS20140732","journal-title":"Clin Sci"},{"key":"1410_CR5","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1136\/gutjnl-2020-321767","volume":"70","author":"MB Afonso","year":"2021","unstructured":"Afonso MB, Rodrigues PM, Mateus-Pinheiro M, Sim\u00e3o AL, Gaspar MM, Majdi A, Arretxe E, Alonso C, Santos-Laso A, Jimenez-Ag\u00fcero R (2021) RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease. Gut 70:2359\u20132372","journal-title":"Gut"},{"key":"1410_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/13543784.2020.1708899","volume":"29","author":"N Alkhouri","year":"2020","unstructured":"Alkhouri N (2020) Thyromimetics as emerging therapeutic agents for nonalcoholic steatohepatitis: rationale for the development of resmetirom (MGL-3196). Expert Opin Investig Drugs 29:99\u2013101. https:\/\/doi.org\/10.1080\/13543784.2020.1708899","journal-title":"Expert Opin Investig Drugs"},{"key":"1410_CR7","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","volume":"10","author":"QM Anstee","year":"2013","unstructured":"Anstee QM, Day CP (2013) The genetics of NAFLD. Nat Rev Gastroenterol Hepatol 10:645\u2013655. https:\/\/doi.org\/10.1038\/nrgastro.2013.182","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1410_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s40495-017-0085-2","volume":"3","author":"LE Armstrong","year":"2017","unstructured":"Armstrong LE, Guo GL (2017) Role of FXR in liver inflammation during nonalcoholic steatohepatitis. Curr Pharmacol Rep 3:92\u2013100. https:\/\/doi.org\/10.1007\/s40495-017-0085-2","journal-title":"Curr Pharmacol Rep"},{"key":"1410_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.tem.2014.03.002","volume":"25","author":"P Arner","year":"2014","unstructured":"Arner P, Langin D (2014) Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance. Trends Endocrinol Metab 25:255\u2013262. https:\/\/doi.org\/10.1016\/j.tem.2014.03.002","journal-title":"Trends Endocrinol Metab"},{"key":"1410_CR10","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/s41366-021-00998-w","volume":"46","author":"IA Arnoldussen","year":"2022","unstructured":"Arnoldussen IA, Morrison MC, Wiesmann M, Van Diepen JA, Worms N, Voskuilen M, Verweij V, Geenen B, Gualdo NP, Van Der Logt L (2022) Milk fat globule membrane attenuates high fat diet-induced neuropathological changes in obese Ldlr\u2212\/\u2212. Leiden mice. Int J Obes 46:342\u2013349","journal-title":"Int J Obes"},{"key":"1410_CR11","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1210\/me.2005-0494","volume":"20","author":"T Arsov","year":"2006","unstructured":"Arsov T, Silva DG, O\u2019bryan, M. K., Sainsbury, A., Lee, N. J., Kennedy, C., Manji, S. S., Nelms, K., Liu, C., and Vinuesa, C. G. (2006) Fat aussie\u2014a new Alstrom syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis. Mol Endocrinol 20:1610\u20131622. https:\/\/doi.org\/10.1210\/me.2005-0494","journal-title":"Mol Endocrinol"},{"key":"1410_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jhep.2016.05.005","volume":"65","author":"A Asgharpour","year":"2016","unstructured":"Asgharpour A, Cazanave SC, Pacana T, Seneshaw M, Vincent R, Banini BA, Kumar DP, Daita K, Min HK, Mirshahi F, Bedossa P, Sun X, Hoshida Y, Koduru SV, Contaifer D Jr, Warncke UO, Wijesinghe DS, Sanyal AJ (2016) A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. J Hepatol 65:579\u2013588. https:\/\/doi.org\/10.1016\/j.jhep.2016.05.005","journal-title":"J Hepatol"},{"key":"1410_CR13","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.cgh.2017.06.011","volume":"15","author":"L Avery","year":"2017","unstructured":"Avery L, Exley C, Mcpherson S, Trenell MI, Anstee QM, Hallsworth K (2017) Lifestyle behavior change in patients with nonalcoholic fatty liver disease: a qualitative study of clinical practice. Clin Gastroenterol Hepatol 15:1968\u20131971. https:\/\/doi.org\/10.1016\/j.cgh.2017.06.011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1410_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cell.2005.08.035","volume":"123","author":"N Balthasar","year":"2005","unstructured":"Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H, Williams T, Ferreira M, Tang V, Mcgovern RA, Kenny CD, Christiansen LM, Edelstein E, Choi B, Boss O, Aschkenasi C, Zhang CY, Mountjoy K, Kishi T, Elmquist JK, Lowell BB (2005) Divergence of melanocortin pathways in the control of food intake and energy expenditure. Cell 123:493\u2013505. https:\/\/doi.org\/10.1016\/j.cell.2005.08.035","journal-title":"Cell"},{"key":"1410_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3978\/j.issn.2304-3881.2014.11.05","volume":"4","author":"M Basaranoglu","year":"2015","unstructured":"Basaranoglu M, Basaranoglu G, Bugianesi E (2015) Carbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destruction. Hepatobiliary Surg Nut 4:109. https:\/\/doi.org\/10.3978\/j.issn.2304-3881.2014.11.05","journal-title":"Hepatobiliary Surg Nut"},{"key":"1410_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000498946","volume":"13","author":"WP Bastian","year":"2019","unstructured":"Bastian WP, Hasan I, Lesmana CRA, Rinaldi I, Gani RA (2019) Gut microbiota profiles in nonalcoholic fatty liver disease and its possible impact on disease progression evaluated with transient elastography: lesson learnt from 60 cases. Case Rep Gastroenterol 13:125\u2013133. https:\/\/doi.org\/10.1159\/000498946","journal-title":"Case Rep Gastroenterol"},{"key":"1410_CR17","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2020.04.037","volume":"73","author":"J Bates","year":"2020","unstructured":"Bates J, Vijayakumar A, Ghoshal S, Marchand B, Yi S, Kornyeyev D, Zagorska A, Hollenback D, Walker K, Liu K (2020) Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation. J Hepatol 73:896\u2013905","journal-title":"J Hepatol"},{"key":"1410_CR18","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1093\/hmg\/ddp357","volume":"18","author":"NL Beer","year":"2009","unstructured":"Beer NL, Tribble ND, Mcculloch LJ, Roos C, Johnson PR, Orho-Melander M, Gloyn AL (2009) The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver. Hum Mol Genet 18:4081\u20134088. https:\/\/doi.org\/10.1093\/hmg\/ddp357","journal-title":"Hum Mol Genet"},{"key":"1410_CR19","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.jhep.2008.01.035","volume":"48","author":"I Bergheim","year":"2008","unstructured":"Bergheim I, Weber S, Vos M, Kramer S, Volynets V, Kaserouni S, Mcclain CJ, Bischoff SC (2008) Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 48:983\u2013992. https:\/\/doi.org\/10.1016\/j.jhep.2008.01.035","journal-title":"J Hepatol"},{"key":"1410_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100237","volume":"3","author":"D Bhattacharya","year":"2021","unstructured":"Bhattacharya D, Basta B, Mato JM, Craig A, Fernandez-Ramos D, Lopitz-Otsoa F, Tsvirkun D, Hayardeny L, Chandar V, Schwartz RE, Villanueva A, Friedman SL (2021) Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis. JHEP Rep 3:100237. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100237","journal-title":"JHEP Rep"},{"key":"1410_CR21","doi-asserted-by":"publisher","first-page":"4904","DOI":"10.3748\/wjg.v25.i33.4904","volume":"25","author":"ML Boland","year":"2019","unstructured":"Boland ML, Oro D, Tolbol KS, Thrane ST, Nielsen JC, Cohen TS, Tabor DE, Fernandes F, Tovchigrechko A, Veidal SS, Warrener P, Sellman BR, Jelsing J, Feigh M, Vrang N, Trevaskis JL, Hansen HH (2019) Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source. World J Gastroenterol 25:4904\u20134920. https:\/\/doi.org\/10.3748\/wjg.v25.i33.4904","journal-title":"World J Gastroenterol"},{"key":"1410_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s1383-5742(02)00044-3","volume":"512","author":"AD Bolzan","year":"2002","unstructured":"Bolzan AD, Bianchi MS (2002) Genotoxicity of streptozotocin. Mutat Res 512:121\u2013134. https:\/\/doi.org\/10.1016\/s1383-5742(02)00044-3","journal-title":"Mutat Res"},{"key":"1410_CR23","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","volume":"63","author":"J Boursier","year":"2016","unstructured":"Boursier J, Mueller O, Barret M, Machado M, Fizanne L, Araujo-Perez F, Guy CD, Seed PC, Rawls JF, David LA (2016) The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 63:764\u2013775. https:\/\/doi.org\/10.1002\/hep.28356","journal-title":"Hepatology"},{"key":"1410_CR24","doi-asserted-by":"publisher","first-page":"G194","DOI":"10.1152\/ajpgi.00413.2005","volume":"290","author":"MW Bradbury","year":"2006","unstructured":"Bradbury MW (2006) Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis. Am J Physiol Gastrointest Liver Physiol 290:G194\u2013G198. https:\/\/doi.org\/10.1152\/ajpgi.00413.2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1410_CR25","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/mog.0000000000000349","volume":"33","author":"K Brandl","year":"2017","unstructured":"Brandl K, Schnabl B (2017) Intestinal microbiota and nonalcoholic steatohepatitis. Curr Opin Gastroenterol 33:128\u2013133. https:\/\/doi.org\/10.1097\/mog.0000000000000349","journal-title":"Curr Opin Gastroenterol"},{"key":"1410_CR26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/ncpendmet0196","volume":"2","author":"AM Brennan","year":"2006","unstructured":"Brennan AM, Mantzoros CS (2006) Drug Insight: the role of leptin in human physiology and pathophysiology\u2014emerging clinical applications. Nat Clin Pract Endocrinol Metab 2:318\u2013327. https:\/\/doi.org\/10.1038\/ncpendmet0196","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"1410_CR27","doi-asserted-by":"publisher","first-page":"003","DOI":"10.1055\/s-2001-12925","volume":"21","author":"EM Brunt","year":"2001","unstructured":"Brunt EM (2001) Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 21:003\u2013016. https:\/\/doi.org\/10.1055\/s-2001-12925","journal-title":"Semin Liver Dis"},{"key":"1410_CR28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000341127","volume":"30","author":"EM Brunt","year":"2012","unstructured":"Brunt EM (2012) Nonalcoholic fatty liver disease: what the pathologist can tell the clinician. Dig Dis 30:61\u201368. https:\/\/doi.org\/10.1159\/000341127","journal-title":"Dig Dis"},{"key":"1410_CR29","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/hep.22724","volume":"49","author":"EM Brunt","year":"2009","unstructured":"Brunt EM, Kleiner DE, Wilson LA, Unalp A, Behling CE, Lavine JE, Neuschwander-Tetri BA, Appendix NCRNLOMOTNSCRNCBFIT (2009) Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. Hepatology 49:809\u2013820. https:\/\/doi.org\/10.1002\/hep.22724","journal-title":"Hepatology"},{"key":"1410_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cphy.c170040","volume":"9","author":"MS Burhans","year":"2018","unstructured":"Burhans MS, Hagman DK, Kuzma JN, Schmidt KA, Kratz M (2018) Contribution of adipose tissue inflammation to the development of type 2 diabetes mellitus. Compr Physiol 9:1\u201358. https:\/\/doi.org\/10.1002\/cphy.c170040","journal-title":"Compr Physiol"},{"key":"1410_CR31","doi-asserted-by":"publisher","first-page":"18528","DOI":"10.1074\/jbc.M109.099333","volume":"285","author":"F Caballero","year":"2010","unstructured":"Caballero F, Fern\u00e1ndez A, Mat\u00edas N, Mart\u00ednez L, Fucho R, Elena M, Caballeria J, Morales A, Fern\u00e1ndez-Checa JC, Garc\u00eda-Ruiz C (2010) Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione. J Biol Chem 285:18528\u201318536. https:\/\/doi.org\/10.1074\/jbc.M109.099333","journal-title":"J Biol Chem"},{"key":"1410_CR32","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jhep.2010.04.031","volume":"53","author":"S Caldwell","year":"2010","unstructured":"Caldwell S, Ikura Y, Dias D, Isomoto K, Yabu A, Moskaluk C, Pramoonjago P, Simmons W, Scruggs H, Rosenbaum N, Wilkinson T, Toms P, Argo CK, Al-Osaimi AM, Redick JA (2010) Hepatocellular ballooning in NASH. J Hepatol 53:719\u2013723. https:\/\/doi.org\/10.1016\/j.jhep.2010.04.031","journal-title":"J Hepatol"},{"key":"1410_CR33","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/s41591-021-01489-1","volume":"27","author":"RA Calle","year":"2021","unstructured":"Calle RA, Amin NB, Carvajal-Gonzalez S, Ross TT, Bergman A, Aggarwal S, Crowley C, Rinaldi A, Mancuso J, Aggarwal N, Somayaji V, Inglot M, Tuthill TA, Kou K, Boucher M, Tesz G, Dullea R, Bence KK, Kim AM, Pfefferkorn JA, Esler WP (2021) ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials. Nat Med 27:1836\u20131848. https:\/\/doi.org\/10.1038\/s41591-021-01489-1","journal-title":"Nat Med"},{"key":"1410_CR34","doi-asserted-by":"publisher","first-page":"42801","DOI":"10.1038\/srep42801","volume":"7","author":"A Carino","year":"2017","unstructured":"Carino A, Cipriani S, Marchian\u00f2 S, Biagioli M, Santorelli C, Donini A, Zampella A, Monti MC, Fiorucci S (2017) BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis. Sci Rep 7:42801. https:\/\/doi.org\/10.1038\/srep42801","journal-title":"Sci Rep"},{"key":"1410_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cellsig.2005.08.009","volume":"18","author":"G-Y Carmen","year":"2006","unstructured":"Carmen G-Y, V\u00edctor S-M (2006) Signalling mechanisms regulating lipolysis. Cell Signal 18:401\u2013408. https:\/\/doi.org\/10.1016\/j.cellsig.2005.08.009","journal-title":"Cell Signal"},{"key":"1410_CR36","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1111\/j.1572-0241.2003.08767.x","volume":"98","author":"N Chalasani","year":"2003","unstructured":"Chalasani N, Crabb DW, Cummings OW, Kwo PY, Asghar A, Pandya PK, Considine RV (2003) Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? Am J Gastroenterol 98:2771\u20132776. https:\/\/doi.org\/10.1111\/j.1572-0241.2003.08767.x","journal-title":"Am J Gastroenterol"},{"key":"1410_CR37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2008.01.016","volume":"48","author":"N Chalasani","year":"2008","unstructured":"Chalasani N, Wilson L, Kleiner DE, Cummings OW, Brunt EM, Unalp A, Network NCR (2008) Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. J Hepatol 48:829\u2013834. https:\/\/doi.org\/10.1016\/j.jhep.2008.01.016","journal-title":"J Hepatol"},{"key":"1410_CR38","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67:328\u2013357. https:\/\/doi.org\/10.1002\/hep.29367","journal-title":"Hepatology"},{"issue":"1334\u20131345","key":"1410_CR39","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.11.296","volume":"158","author":"Chalasani, N., Abdelmalek, M. F., Garcia-Tsao, G., Vuppalanchi, R., Alkhouri, N., Rinella, M., Noureddin, M., Pyko, M., Shiffman, M., Sanyal, A., Allgood, A., Shlevin, H., Horton, R., Zomer, E., Irish, W., Goodman, Z., Harrison, S. A., Traber, P. G., and Belapectin Study, I","year":"2020","unstructured":"Chalasani, N., Abdelmalek, M. F., Garcia-Tsao, G., Vuppalanchi, R., Alkhouri, N., Rinella, M., Noureddin, M., Pyko, M., Shiffman, M., Sanyal, A., Allgood, A., Shlevin, H., Horton, R., Zomer, E., Irish, W., Goodman, Z., Harrison, S. A., Traber, P. G., and Belapectin Study, I (2020) Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension. Gastroenterology 158(1334\u20131345):e5. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.296","journal-title":"Gastroenterology"},{"key":"1410_CR40","doi-asserted-by":"publisher","first-page":"G825","DOI":"10.1152\/ajpgi.00145.2011","volume":"301","author":"M Charlton","year":"2011","unstructured":"Charlton M, Krishnan A, Viker K, Sanderson S, Cazanave S, Mcconico A, Masuoko H, Gores G (2011) Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol 301:G825\u2013G834. https:\/\/doi.org\/10.1152\/ajpgi.00145.2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1410_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.bbcan.2018.11.005","volume":"1871","author":"K Chen","year":"2019","unstructured":"Chen K, Ma J, Jia X, Ai W, Ma Z, Pan Q (2019) Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans. Biochim Biophys Acta Rev Cancer 1871:117\u2013125. https:\/\/doi.org\/10.1016\/j.bbcan.2018.11.005","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"1410_CR42","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/liv.12741","volume":"35","author":"HK Chung","year":"2015","unstructured":"Chung HK, Kim YK, Park JH, Ryu MJ, Chang JY, Hwang JH, Lee CH, Kim SH, Kim HJ, Kweon GR, Kim KS, Shong M (2015) The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob\/ob mice through suppression of mitochondrial ROS\/RNS and inflammation. Liver Int 35:1341\u20131353. https:\/\/doi.org\/10.1111\/liv.12741","journal-title":"Liver Int"},{"key":"1410_CR43","doi-asserted-by":"publisher","first-page":"G483","DOI":"10.1152\/ajpgi.00079.2013","volume":"305","author":"JR Clapper","year":"2013","unstructured":"Clapper JR, Hendricks MD, Gu G, Wittmer C, Dolman CS, Herich J, Athanacio J, Villescaz C, Ghosh SS, Heilig JS, Lowe C, Roth JD (2013) Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment. Am J Physiol Gastrointest Liver Physiol 305:G483\u2013G495. https:\/\/doi.org\/10.1152\/ajpgi.00079.2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1410_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep.24341","volume":"54","author":"T Csak","year":"2011","unstructured":"Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G (2011) Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 54:133\u2013144. https:\/\/doi.org\/10.1002\/hep.24341","journal-title":"Hepatology"},{"issue":"711\u2013725","key":"1410_CR45","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.02.003","volume":"142","author":"K Cusi","year":"2012","unstructured":"Cusi K (2012) Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. Gastroenterology 142(711\u2013725):e6. https:\/\/doi.org\/10.1053\/j.gastro.2012.02.003","journal-title":"Gastroenterology"},{"key":"1410_CR46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1478-3231.2006.01405.x","volume":"27","author":"VM De Lima","year":"2007","unstructured":"De Lima VM, De Oliveira CP, Sawada LY, Barbeiro HV, De Mello ES, Soriano FG, Alves VA, Caldwell SH, Carrilho FJ (2007) Yo jyo hen shi ko, a novel Chinese herbal, prevents nonalcoholic steatohepatitis in ob\/ob mice fed a high fat or methionine-choline-deficient diet. Liver Int 27:227\u2013234. https:\/\/doi.org\/10.1111\/j.1478-3231.2006.01405.x","journal-title":"Liver Int"},{"key":"1410_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097136","volume":"9","author":"S De Minicis","year":"2014","unstructured":"De Minicis S, Agostinelli L, Rychlicki C, Sorice GP, Saccomanno S, Candelaresi C, Giaccari A, Trozzi L, Pierantonelli I, Mingarelli E (2014) HCC development is associated to peripheral insulin resistance in a mouse model of NASH. PLoS ONE 9:e97136. https:\/\/doi.org\/10.1371\/journal.pone.0097136","journal-title":"PLoS ONE"},{"key":"1410_CR48","doi-asserted-by":"publisher","first-page":"G424","DOI":"10.1152\/ajpgi.2002.282.3.G424","volume":"282","author":"S Delgado-Aros","year":"2002","unstructured":"Delgado-Aros S, Kim DY, Burton DD, Thomforde GM, Stephens D, Brinkmann BH, Vella A, Camilleri M (2002) Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol Gastrointest Liver Physiol 282:G424\u2013G431. https:\/\/doi.org\/10.1152\/ajpgi.2002.282.3.G424","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1410_CR49","doi-asserted-by":"publisher","first-page":"53","DOI":"10.14218\/jcth.2014.00035","volume":"3","author":"B Delire","year":"2015","unstructured":"Delire B, St\u00e4rkel P, Leclercq I (2015) Animal models for fibrotic liver diseases: what we have, what we need, and what is under development. J Clin Transl Hepatol 3:53\u201366. https:\/\/doi.org\/10.14218\/jcth.2014.00035","journal-title":"J Clin Transl Hepatol"},{"key":"1410_CR50","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G Den Besten","year":"2013","unstructured":"Den Besten G, Van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54:2325\u20132340. https:\/\/doi.org\/10.1194\/jlr.R036012","journal-title":"J Lipid Res"},{"key":"1410_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1349-7006.2002.tb01250.x","volume":"93","author":"A Denda","year":"2002","unstructured":"Denda A, Kitayama W, Kishida H, Murata N, Tsutsumi M, Tsujiuchi T, Nakae D, Konishi Y (2002) Development of hepatocellular adenomas and carcinomas associated with fibrosis in C57BL\/6J male mice given a choline-deficient, L-amino acid-defined diet. Jpn J Cancer Res 93:125\u2013132. https:\/\/doi.org\/10.1111\/j.1349-7006.2002.tb01250.x","journal-title":"Jpn J Cancer Res"},{"key":"1410_CR52","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/hep.20877","volume":"42","author":"QG Deng","year":"2005","unstructured":"Deng QG, She H, Cheng JH, French SW, Koop DR, Xiong S, Tsukamoto H (2005) Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 42:905\u2013914. https:\/\/doi.org\/10.1002\/hep.20877","journal-title":"Hepatology"},{"key":"1410_CR53","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.biochi.2004.11.008","volume":"87","author":"R Dentin","year":"2005","unstructured":"Dentin R, Girard J, Postic C (2005) Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie 87:81\u201386. https:\/\/doi.org\/10.1016\/j.biochi.2004.11.008","journal-title":"Biochimie"},{"key":"1410_CR54","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40265-018-0871-0","volume":"78","author":"S Dhillon","year":"2018","unstructured":"Dhillon S (2018) Semaglutide: first global approval. Drugs 78:275\u2013284. https:\/\/doi.org\/10.1007\/s40265-018-0871-0","journal-title":"Drugs"},{"key":"1410_CR55","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.21006","volume":"43","author":"X Ding","year":"2006","unstructured":"Ding X, Saxena NK, Lin S, Gupta NA, Anania FA (2006) Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob\/ob mice. Hepatology 43:173\u2013181. https:\/\/doi.org\/10.1002\/hep.21006","journal-title":"Hepatology"},{"key":"1410_CR56","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ajpath.2014.01.034","volume":"184","author":"JK Dowman","year":"2014","unstructured":"Dowman JK, Hopkins LJ, Reynolds GM, Nikolaou N, Armstrong MJ, Shaw JC, Houlihan DD, Lalor PF, Tomlinson JW, H\u00fcbscher SG (2014) Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat\/fructose diet and sedentary lifestyle. Am J Pathol 184:1550\u20131561. https:\/\/doi.org\/10.1016\/j.ajpath.2014.01.034","journal-title":"Am J Pathol"},{"key":"1410_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179808","volume":"12","author":"BA Droz","year":"2017","unstructured":"Droz BA, Sneed BL, Jackson CV, Zimmerman KM, Michael MD, Emmerson PJ, Coskun T, Peterson RG (2017) Correlation of disease severity with body weight and high fat diet in the FATZO\/Pco mouse. PLoS ONE 12:e0179808. https:\/\/doi.org\/10.1371\/journal.pone.0179808","journal-title":"PLoS ONE"},{"key":"1410_CR58","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/ars.2010.3395","volume":"15","author":"HB Eccleston","year":"2011","unstructured":"Eccleston HB, Andringa KK, Betancourt AM, King AL, Mantena SK, Swain TM, Tinsley HN, Nolte RN, Nagy TR, Abrams GA, Bailey SM (2011) Chronic exposure to a high-fat diet induces hepatic steatosis, impairs nitric oxide bioavailability, and modifies the mitochondrial proteome in mice. Antioxid Redox Signal 15:447\u2013459. https:\/\/doi.org\/10.1089\/ars.2010.3395","journal-title":"Antioxid Redox Signal"},{"key":"1410_CR59","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt M, Hagstr\u00f6m H, Nasr P, Fredrikson M, St\u00e5l P, Kechagias S, Hultcrantz R (2015) Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 61:1547\u20131554. https:\/\/doi.org\/10.1002\/hep.27368","journal-title":"Hepatology"},{"key":"1410_CR60","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1037\/bne0000252","volume":"132","author":"KM Emmer","year":"2018","unstructured":"Emmer KM, Russart KL, Walker Ii WH, Nelson RJ, Devries AC (2018) Effects of light at night on laboratory animals and research outcomes. Behav Neurosci 132:302. https:\/\/doi.org\/10.1037\/bne0000252","journal-title":"Behav Neurosci"},{"key":"1410_CR61","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1080\/07420520902821176","volume":"26","author":"Y Esquirol","year":"2009","unstructured":"Esquirol Y, Bongard V, Mabile L, Jonnier B, Soulat JM, Perret B (2009) Shift work and metabolic syndrome: respective impacts of job strain, physical activity, and dietary rhythms. Chronobiol Int 26:544\u2013559. https:\/\/doi.org\/10.1080\/07420520902821176","journal-title":"Chronobiol Int"},{"key":"1410_CR62","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/liv.12335","volume":"34","author":"GC Farrell","year":"2014","unstructured":"Farrell GC, Mridha AR, Yeh MM, Arsov T, Van Rooyen DM, Brooling J, Nguyen T, Heydet D, Delghingaro-Augusto V, Nolan CJ, Shackel NA, Mclennan SV, Teoh NC, Larter CZ (2014) Strain dependence of diet-induced NASH and liver fibrosis in obese mice is linked to diabetes and inflammatory phenotype. Liver Int 34:1084\u20131093. https:\/\/doi.org\/10.1111\/liv.12335","journal-title":"Liver Int"},{"key":"1410_CR63","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1002\/hep.30333","volume":"69","author":"G Farrell","year":"2019","unstructured":"Farrell G, Schattenberg JM, Leclercq I, Yeh MM, Goldin R, Teoh N, Schuppan D (2019) Mouse models of nonalcoholic steatohepatitis: toward optimization of their relevance to human nonalcoholic steatohepatitis. Hepatology 69:2241\u20132257. https:\/\/doi.org\/10.1002\/hep.30333","journal-title":"Hepatology"},{"key":"1410_CR64","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s0016-5085(03)00907-7","volume":"125","author":"AE Feldstein","year":"2003","unstructured":"Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ (2003) Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125:437\u2013443. https:\/\/doi.org\/10.1016\/s0016-5085(03)00907-7","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"1410_CR65","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","volume":"12","author":"P Ferre","year":"2010","unstructured":"Ferre P, Foufelle F (2010) Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 12(Suppl 2):83\u201392. https:\/\/doi.org\/10.1111\/j.1463-1326.2010.01275.x","journal-title":"Diabetes Obes Metab"},{"key":"1410_CR66","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jnutbio.2018.09.007","volume":"62","author":"KFT Flister","year":"2018","unstructured":"Flister KFT, Pinto B, a. S., Franca, L. M., Coelho, C. F. F., Dos Santos, P. C., Vale, C. C., Kajihara, D., Debbas, V., Laurindo, F. R. M., and Paes, A. M. A. (2018) Long-term exposure to high-sucrose diet down-regulates hepatic endoplasmic reticulum-stress adaptive pathways and potentiates de novo lipogenesis in weaned male mice. J Nutr Biochem 62:155\u2013166. https:\/\/doi.org\/10.1016\/j.jnutbio.2018.09.007","journal-title":"J Nutr Biochem"},{"key":"1410_CR67","doi-asserted-by":"publisher","first-page":"18664","DOI":"10.1073\/pnas.1008734107","volume":"107","author":"LK Fonken","year":"2010","unstructured":"Fonken LK, Workman JL, Walton JC, Weil ZM, Morris JS, Haim A, Nelson RJ (2010) Light at night increases body mass by shifting the time of food intake. Proc Natl Acad Sci U S A 107:18664\u201318669. https:\/\/doi.org\/10.1073\/pnas.1008734107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1410_CR68","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","volume":"81","author":"BM Forman","year":"1995","unstructured":"Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, Mcmorris T, Lamph WW (1995) Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81:687\u2013693. https:\/\/doi.org\/10.1016\/0092-8674(95)90530-8","journal-title":"Cell"},{"key":"1410_CR69","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.2147\/DDDT.S315724","volume":"15","author":"JM Fraile","year":"2021","unstructured":"Fraile JM, Palliyil S, Barelle C, Porter AJ, Kovaleva M (2021) Non-alcoholic steatohepatitis (NASH)\u2013A review of a crowded clinical landscape, driven by a complex disease. Drug Des Dev Ther 15:3997. https:\/\/doi.org\/10.2147\/DDDT.S315724","journal-title":"Drug Des Dev Ther"},{"key":"1410_CR70","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","volume":"63","author":"S Francque","year":"2015","unstructured":"Francque S, Verrijken A, Caron S, Prawitt J, Paumelle R, Derudas B, Lefebvre P, Taskinen MR, Van Hul W, Mertens I, Hubens G, Van Marck E, Michielsen P, Van Gaal L, Staels B (2015) PPAR\u03b1 gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis. J Hepatol 63:164\u2013173. https:\/\/doi.org\/10.1016\/j.jhep.2015.02.019","journal-title":"J Hepatol"},{"key":"1410_CR71","doi-asserted-by":"publisher","first-page":"9A","DOI":"10.1002\/hep.31578","volume":"72","author":"S Francque","year":"2020","unstructured":"Francque S, Bedossa P, Ratziu V, Anstee Q, Bugianesi E, Sanyal A, Loomba R, Harrison SA, Balabanska RI, Mateva L (2020) The panPPAR agonist lanifibranor induces both resolution of NASH and regression of fibrosis after 24 weeks of treatment in non-cirrhotic nash: Results of the NATIVE phase 2b trial. Hepatology 72:9A. https:\/\/doi.org\/10.1002\/hep.31578","journal-title":"Hepatology"},{"key":"1410_CR72","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (2018) Mechanisms of NAFLD development and therapeutic strategies. Nat Med 24:908\u2013922. https:\/\/doi.org\/10.1038\/s41591-018-0104-9","journal-title":"Nat Med"},{"key":"1410_CR73","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","volume":"46","author":"M Fujii","year":"2013","unstructured":"Fujii M, Shibazaki Y, Wakamatsu K, Honda Y, Kawauchi Y, Suzuki K, Arumugam S, Watanabe K, Ichida T, Asakura H (2013) A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma. Med Mol Morphol 46:141\u2013152. https:\/\/doi.org\/10.1007\/s00795-013-0016-1","journal-title":"Med Mol Morphol"},{"key":"1410_CR74","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.78","volume":"1","author":"BL Furman","year":"2021","unstructured":"Furman BL (2021) Streptozotocin-induced diabetic models in mice and rats. Curr Protoc 1:e78. https:\/\/doi.org\/10.1002\/cpz1.78","journal-title":"Curr Protoc"},{"key":"1410_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2021.05.010","author":"S Ganguly","year":"2021","unstructured":"Ganguly S, Muench GA, Shang L, Rosenthal SB, Rahman G, Wang R, Wang Y, Kwon HC, Diomino AM, Kisseleva T (2021) Non-alcoholic steatohepatitis and HCC in a hyperphagic mouse accelerated by Western diet. Cell Mol Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.05.010","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1410_CR76","doi-asserted-by":"publisher","first-page":"8525","DOI":"10.3748\/wjg.v20.i26.8525","volume":"20","author":"M Ganz","year":"2014","unstructured":"Ganz M, Csak T, Szabo G (2014) High fat diet feeding results in gender specific steatohepatitis and inflammasome activation. World J Gastroenterol 20:8525\u20138534. https:\/\/doi.org\/10.3748\/wjg.v20.i26.8525","journal-title":"World J Gastroenterol"},{"key":"1410_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20010001","volume":"20","author":"E Gart","year":"2018","unstructured":"Gart E, Souto Lima E, Schuren F, De Ruiter CG, Attema J, Verschuren L, Keijer J, Salic K, Morrison MC, Kleemann R (2018) Diet-independent correlations between bacteria and dysfunction of gut, adipose tissue, and liver: A comprehensive microbiota analysis in feces and mucosa of the ileum and colon in obese mice with NAFLD. Int J Mol Sci 20:1","journal-title":"Int J Mol Sci"},{"key":"1410_CR78","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/hep.31843","volume":"74","author":"S Gawrieh","year":"2021","unstructured":"Gawrieh S, Noureddin M, Loo N, Mohseni R, Awasty V, Cusi K (2021) Saroglitazar, a PPAR-a\/a agonist, for treatment of NAFLD: A randomized controlled double-blind phase 2 trial. Hepatology 74:1809\u20131824. https:\/\/doi.org\/10.1002\/hep.31843","journal-title":"Hepatology"},{"key":"1410_CR79","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.molmet.2016.09.008","volume":"5","author":"DA Giles","year":"2016","unstructured":"Giles DA, Ramkhelawon B, Donelan EM, Stankiewicz TE, Hutchison SB, Mukherjee R, Cappelletti M, Karns R, Karp CL, Moore KJ, Divanovic S (2016) Modulation of ambient temperature promotes inflammation and initiates atherosclerosis in wild type C57BL\/6 mice. Mol Metab 5:1121\u20131130. https:\/\/doi.org\/10.1016\/j.molmet.2016.09.008","journal-title":"Mol Metab"},{"key":"1410_CR80","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nm.4346","volume":"23","author":"DA Giles","year":"2017","unstructured":"Giles DA, Moreno-Fernandez ME, Stankiewicz TE, Graspeuntner S, Cappelletti M, Wu D, Mukherjee R, Chan CC, Lawson MJ, Klarquist J (2017) Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling. Nat Med 23:829. https:\/\/doi.org\/10.1038\/nm.4346","journal-title":"Nat Med"},{"key":"1410_CR81","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1002\/hep.30765","volume":"70","author":"NL Gluchowski","year":"2019","unstructured":"Gluchowski NL, Gabriel KR, Chitraju C, Bronson RT, Mejhert N, Boland S, Wang K, Lai ZW, Farese RV Jr, Walther TC (2019) Hepatocyte deletion of triglyceride-synthesis Enzyme Acyl CoA: diacylglycerol acyltransferase 2 reduces steatosis without increasing inflammation or fibrosis in mice. Hepatology 70:1972\u20131985. https:\/\/doi.org\/10.1002\/hep.30765","journal-title":"Hepatology"},{"key":"1410_CR82","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/s1097-2765(00)00051-4","volume":"6","author":"B Goodwin","year":"2000","unstructured":"Goodwin B, Jones SA, Price RR, Watson MA, Mckee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA (2000) A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6:517\u2013526. https:\/\/doi.org\/10.1016\/s1097-2765(00)00051-4","journal-title":"Mol Cell"},{"key":"1410_CR83","doi-asserted-by":"publisher","first-page":"E363","DOI":"10.1152\/ajpendo.1980.239.5.E363","volume":"239","author":"ML Grundleger","year":"1980","unstructured":"Grundleger ML, Godbole VY, Thenen SW (1980) Age-dependent development of insulin resistance of soleus muscle in genetically obese (ob\/ob) mice. Am J Physiol 239:E363\u2013E371. https:\/\/doi.org\/10.1152\/ajpendo.1980.239.5.E363","journal-title":"Am J Physiol"},{"key":"1410_CR84","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrm2391","volume":"9","author":"A Guilherme","year":"2008","unstructured":"Guilherme A, Virbasius JV, Puri V, Czech MP (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367\u2013377. https:\/\/doi.org\/10.1038\/nrm2391","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1410_CR85","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S1665-2681(19)31616-3","volume":"9","author":"Y Gutierrez-Grobe","year":"2010","unstructured":"Gutierrez-Grobe Y, Ponciano-Rodriguez G, Ramos MH, Uribe M, Mendez-Sanchez N (2010) Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann Hepatol 9:402\u2013409. https:\/\/doi.org\/10.1016\/S1665-2681(19)31616-3","journal-title":"Ann Hepatol"},{"key":"1410_CR86","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/oby.21170","volume":"23","author":"F Haczeyni","year":"2015","unstructured":"Haczeyni F, Barn V, Mridha AR, Yeh MM, Estevez E, Febbraio MA, Nolan CJ, Bell-Anderson KS, Teoh NC, Farrell GC (2015) Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice. Obesity (silver Spring) 23:1845\u20131855. https:\/\/doi.org\/10.1002\/oby.21170","journal-title":"Obesity (silver Spring)"},{"key":"1410_CR87","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/jgh.14122","volume":"33","author":"F Haczeyni","year":"2018","unstructured":"Haczeyni F, Yeh MM, Ioannou GN, Leclercq IA, Goldin R, Dan YY, Yu J, Teoh NC, Farrell GC (2018) Mouse models of non-alcoholic steatohepatitis: A reflection on recent literature. J Gastroenterol Hepatol 33:1312\u20131320. https:\/\/doi.org\/10.1111\/jgh.14122","journal-title":"J Gastroenterol Hepatol"},{"key":"1410_CR88","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/tbm\/ibz080","volume":"10","author":"K Hallsworth","year":"2020","unstructured":"Hallsworth K, Dombrowski SU, Mcpherson S, Anstee QM, Avery L (2020) Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study. Transl Behav Med 10:1016\u20131030. https:\/\/doi.org\/10.1093\/tbm\/ibz080","journal-title":"Transl Behav Med"},{"key":"1410_CR89","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1194\/jlr.M700184-JLR200","volume":"49","author":"MS Han","year":"2008","unstructured":"Han MS, Park SY, Shinzawa K, Kim S, Chung KW, Lee J-H, Kwon CH, Lee K-W, Lee J-H, Park CK (2008) Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes. J Lipid Res 49:84\u201397. https:\/\/doi.org\/10.1194\/jlr.M700184-JLR200","journal-title":"J Lipid Res"},{"key":"1410_CR90","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1172\/jci124219","volume":"129","author":"YH Han","year":"2019","unstructured":"Han YH, Shin KO, Kim JY, Khadka DB, Kim HJ, Lee YM, Cho WJ, Cha JY, Lee BJ, Lee MO (2019) A maresin 1\/ROR\u03b1\/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis. J Clin Invest 129:1684\u20131698. https:\/\/doi.org\/10.1172\/jci124219","journal-title":"J Clin Invest"},{"key":"1410_CR91","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-pathol-012615-044224","volume":"11","author":"T Hardy","year":"2016","unstructured":"Hardy T, Oakley F, Anstee QM, Day CP (2016) Nonalcoholic fatty liver disease: pathogenesis and disease spectrum. Annu Rev Pathol 11:451\u2013496. https:\/\/doi.org\/10.1146\/annurev-pathol-012615-044224","journal-title":"Annu Rev Pathol"},{"key":"1410_CR92","doi-asserted-by":"publisher","first-page":"G345","DOI":"10.1152\/ajpgi.00055.2020","volume":"319","author":"SE Harris","year":"2020","unstructured":"Harris SE, Poolman TM, Arvaniti A, Cox RD, Gathercole LL, Tomlinson JW (2020) The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 319:G345-g360. https:\/\/doi.org\/10.1152\/ajpgi.00055.2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1410_CR93","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2012.04.019","volume":"15","author":"M Hatori","year":"2012","unstructured":"Hatori M, Vollmers C, Zarrinpar A, Ditacchio L, Bushong EA, Gill S, Leblanc M, Chaix A, Joens M, Fitzpatrick JA (2012) Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab 15:848\u2013860. https:\/\/doi.org\/10.1016\/j.cmet.2012.04.019","journal-title":"Cell Metab"},{"key":"1410_CR94","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrgastro.2010.191","volume":"8","author":"L Hebbard","year":"2011","unstructured":"Hebbard L, George J (2011) Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 8:35\u201344. https:\/\/doi.org\/10.1038\/nrgastro.2010.191","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1410_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/dneu.22031","volume":"73","author":"D Heydet","year":"2013","unstructured":"Heydet D, Chen LX, Larter CZ, Inglis C, Silverman MA, Farrell GC, Leroux MR (2013) A truncating mutation of Alms1 reduces the number of hypothalamic neuronal cilia in obese mice. Dev Neurobiol 73:1\u201313. https:\/\/doi.org\/10.1002\/dneu.22031","journal-title":"Dev Neurobiol"},{"key":"1410_CR96","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.metabol.2016.12.013","volume":"69","author":"T Honda","year":"2017","unstructured":"Honda T, Ishigami M, Luo F, Lingyun M, Ishizu Y, Kuzuya T, Hayashi K, Nakano I, Ishikawa T, Feng GG, Katano Y, Kohama T, Kitaura Y, Shimomura Y, Goto H, Hirooka Y (2017) Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice. Metabolism 69:177\u2013187. https:\/\/doi.org\/10.1016\/j.metabol.2016.12.013","journal-title":"Metabolism"},{"key":"1410_CR97","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/aps.2014.117","volume":"36","author":"XF Huang","year":"2015","unstructured":"Huang XF, Zhao WY, Huang WD (2015) FXR and liver carcinogenesis. Acta Pharmacol Sin 36:37\u201343. https:\/\/doi.org\/10.1038\/aps.2014.117","journal-title":"Acta Pharmacol Sin"},{"key":"1410_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154797","volume":"120","author":"S Huang","year":"2021","unstructured":"Huang S, Wu Y, Zhao Z, Wu B, Sun K, Wang H, Qin L, Bai F, Leng Y, Tang W (2021) A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage. Metabolism 120:154797. https:\/\/doi.org\/10.1016\/j.metabol.2021.154797","journal-title":"Metabolism"},{"key":"1410_CR99","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/hep.20280","volume":"40","author":"JM Hui","year":"2004","unstructured":"Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J (2004) Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40:46\u201354. https:\/\/doi.org\/10.1002\/hep.20280","journal-title":"Hepatology"},{"key":"1410_CR100","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/s0092-8674(00)81865-6","volume":"88","author":"D Huszar","year":"1997","unstructured":"Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131\u2013141. https:\/\/doi.org\/10.1016\/s0092-8674(00)81865-6","journal-title":"Cell"},{"key":"1410_CR101","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/01.hyp.10.5.512","volume":"10","author":"IS Hwang","year":"1987","unstructured":"Hwang IS, Ho H, Hoffman BB, Reaven GM (1987) Fructose-induced insulin resistance and hypertension in rats. Hypertension 10:512\u2013516. https:\/\/doi.org\/10.1161\/01.hyp.10.5.512","journal-title":"Hypertension"},{"key":"1410_CR102","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jhep.2010.09.020","volume":"54","author":"C Iacobini","year":"2011","unstructured":"Iacobini C, Menini S, Ricci C, Blasetti Fantauzzi C, Scipioni A, Salvi L, Cordone S, Delucchi F, Serino M, Federici M, Pricci F, Pugliese G (2011) Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver. J Hepatol 54:975\u2013983. https:\/\/doi.org\/10.1016\/j.jhep.2010.09.020","journal-title":"J Hepatol"},{"key":"1410_CR103","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s10620-015-3977-1","volume":"61","author":"SH Ibrahim","year":"2016","unstructured":"Ibrahim SH, Hirsova P, Malhi H, Gores GJ (2016) Animal models of nonalcoholic steatohepatitis: eat, delete, and inflame. Dig Dis Sci 61:1325\u20131336. https:\/\/doi.org\/10.1007\/s10620-015-3977-1","journal-title":"Dig Dis Sci"},{"key":"1410_CR104","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1073\/pnas.0509592103","volume":"103","author":"T Inagaki","year":"2006","unstructured":"Inagaki T, Moschetta A, Lee YK, Peng L, Zhao G, Downes M, Yu RT, Shelton JM, Richardson JA, Repa JJ, Mangelsdorf DJ, Kliewer SA (2006) Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A 103:3920\u20133925. https:\/\/doi.org\/10.1073\/pnas.0509592103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1410_CR105","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","volume":"27","author":"GN Ioannou","year":"2016","unstructured":"Ioannou GN (2016) The role of cholesterol in the pathogenesis of NASH. Trends Endocrinol Metab 27:84\u201395. https:\/\/doi.org\/10.1016\/j.tem.2015.11.008","journal-title":"Trends Endocrinol Metab"},{"key":"1410_CR106","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/hep.20170","volume":"39","author":"E Ip","year":"2004","unstructured":"Ip E, Farrell G, Hall P, Robertson G, Leclercq I (2004) Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 39:1286\u20131296. https:\/\/doi.org\/10.1002\/hep.20170","journal-title":"Hepatology"},{"key":"1410_CR107","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/hep4.1107","volume":"1","author":"M Iruarrizaga-Lejarreta","year":"2017","unstructured":"Iruarrizaga-Lejarreta M, Varela-Rey M, Fern\u00e1ndez-Ramos D, Mart\u00ednez-Arranz I, Delgado TC, Simon J, Juan VG, Delacruz-Villar L, Azkargorta M, Lavin JL, Mayo R, Van Liempd SM, Aurrekoetxea I, Buqu\u00e9 X, Cave DD, Pe\u00f1a A, Rodr\u00edguez-Cuesta J, Aransay AM, Elortza F, Falc\u00f3n-P\u00e9rez JM, Aspichueta P, Hayardeny L, Noureddin M, Sanyal AJ, Alonso C, Anguita J, Mart\u00ednez-Chantar ML, Lu SC, Mato JM (2017) Role of Aramchol in steatohepatitis and fibrosis in mice. Hepatol Commun 1:911\u2013927. https:\/\/doi.org\/10.1002\/hep4.1107","journal-title":"Hepatol Commun"},{"key":"1410_CR108","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1172\/JCI116663","volume":"92","author":"S Ishibashi","year":"1993","unstructured":"Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J (1993) Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Investig 92:883\u2013893","journal-title":"J Clin Investig"},{"key":"1410_CR109","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s10620-016-4393-x","volume":"62","author":"M Ishioka","year":"2017","unstructured":"Ishioka M, Miura K, Minami S, Shimura Y, Ohnishi H (2017) Altered gut microbiota composition and immune response in experimental steatohepatitis mouse models. Dig Dis Sci 62:396\u2013406. https:\/\/doi.org\/10.1007\/s10620-016-4393-x","journal-title":"Dig Dis Sci"},{"key":"1410_CR110","first-page":"2683","volume":"6","author":"H Itagaki","year":"2013","unstructured":"Itagaki H, Shimizu K, Morikawa S, Ogawa K, Ezaki T (2013) Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice. Int J Clin Exp Pathol 6:2683\u20132696","journal-title":"Int J Clin Exp Pathol"},{"key":"1410_CR111","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1872-034X.2007.00008.x","volume":"37","author":"M Ito","year":"2007","unstructured":"Ito M, Suzuki J, Tsujioka S, Sasaki M, Gomori A, Shirakura T, Hirose H, Ito M, Ishihara A, Iwaasa H, Kanatani A (2007) Longitudinal analysis of murine steatohepatitis model induced by chronic exposure to high-fat diet. Hepatol Res 37:50\u201357. https:\/\/doi.org\/10.1111\/j.1872-034X.2007.00008.x","journal-title":"Hepatol Res"},{"key":"1410_CR112","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1016\/j.ajpath.2011.07.014","volume":"179","author":"M Itoh","year":"2011","unstructured":"Itoh M, Suganami T, Nakagawa N, Tanaka M, Yamamoto Y, Kamei Y, Terai S, Sakaida I, Ogawa Y (2011) Melanocortin 4 receptor\u2013deficient mice as a novel mouse model of nonalcoholic steatohepatitis. Am J Pathol 179:2454\u20132463. https:\/\/doi.org\/10.1016\/j.ajpath.2011.07.014","journal-title":"Am J Pathol"},{"key":"1410_CR113","doi-asserted-by":"publisher","first-page":"E1369","DOI":"10.1073\/pnas.1202464109","volume":"109","author":"K Iwaisako","year":"2012","unstructured":"Iwaisako K, Haimerl M, Paik Y-H, Taura K, Kodama Y, Sirlin C, Yu E, Yu RT, Downes M, Evans RM (2012) Protection from liver fibrosis by a peroxisome proliferator-activated receptor \u03b4 agonist. Proc Natl Acad Sci 109:E1369\u2013E1376","journal-title":"Proc Natl Acad Sci"},{"key":"1410_CR114","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/liv.13634","volume":"38","author":"MR Jain","year":"2018","unstructured":"Jain MR, Giri SR, Bhoi B, Trivedi C, Rath A, Rathod R, Ranvir R, Kadam S, Patel H, Swain P (2018) Dual PPAR \u03b1\/\u03b3 agonist Saroglitazar improves liver histopathology and biochemistry in experimental NASH models. Liver Int 38:1084\u20131094. https:\/\/doi.org\/10.1111\/liv.13634","journal-title":"Liver Int"},{"key":"1410_CR115","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s40261-013-0128-3","volume":"33","author":"RH Jani","year":"2013","unstructured":"Jani RH, Kansagra K, Jain MR, Patel H (2013) Pharmacokinetics, safety, and tolerability of saroglitazar (ZYH1), a predominantly PPARalpha agonist with moderate PPARgamma agonist activity in healthy human subjects. Clin Drug Investig 33:809\u2013816. https:\/\/doi.org\/10.1007\/s40261-013-0128-3","journal-title":"Clin Drug Investig"},{"key":"1410_CR116","doi-asserted-by":"publisher","first-page":"50","DOI":"10.12938\/bmfh.2020-046","volume":"40","author":"COM Jasirwan","year":"2021","unstructured":"Jasirwan COM, Muradi A, Hasan I, Simadibrata M, Rinaldi I (2021) Correlation of gut Firmicutes\/Bacteroidetes ratio with fibrosis and steatosis stratified by body mass index in patients with non-alcoholic fatty liver disease. Biosci Microbiota Food Health 40:50\u201358. https:\/\/doi.org\/10.12938\/bmfh.2020-046","journal-title":"Biosci Microbiota Food Health"},{"key":"1410_CR117","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2119\/molmed.2014.00178","volume":"21","author":"I Jeftic","year":"2015","unstructured":"Jeftic I, Jovicic N, Pantic J, Arsenijevic N, Lukic ML, Pejnovic N (2015) Galectin-3 ablation enhances liver steatosis, but attenuates inflammation and IL-33-dependent fibrosis in obesogenic mouse model of nonalcoholic steatohepatitis. Mol Med 21:453\u2013465. https:\/\/doi.org\/10.2119\/molmed.2014.00178","journal-title":"Mol Med"},{"key":"1410_CR118","doi-asserted-by":"publisher","first-page":"10303","DOI":"10.3390\/ijms221910303","volume":"22","author":"F Jia","year":"2021","unstructured":"Jia F, Hu X, Kimura T, Tanaka N (2021) Impact of dietary fat on the progression of liver fibrosis: lessons from animal and cell studies. Int J Mol Sci 22:10303. https:\/\/doi.org\/10.3390\/ijms221910303","journal-title":"Int J Mol Sci"},{"key":"1410_CR119","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/hep.21752","volume":"46","author":"S Joshi-Barve","year":"2007","unstructured":"Joshi-Barve S, Barve SS, Amancherla K, Gobejishvili L, Hill D, Cave M, Hote P, Mcclain CJ (2007) Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46:823\u2013830. https:\/\/doi.org\/10.1002\/hep.21752","journal-title":"Hepatology"},{"key":"1410_CR120","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.molmet.2017.09.001","volume":"6","author":"H Jouihan","year":"2017","unstructured":"Jouihan H, Will S, Guionaud S, Boland ML, Oldham S, Ravn P, Celeste A, Trevaskis JL (2017) Superior reductions in hepatic steatosis and fibrosis with co-administration of a glucagon-like peptide-1 receptor agonist and obeticholic acid in mice. Mol Metab 6:1360\u20131370. https:\/\/doi.org\/10.1016\/j.molmet.2017.09.001","journal-title":"Mol Metab"},{"key":"1410_CR121","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3181\/00379727-126-32401","volume":"126","author":"A Junod","year":"1967","unstructured":"Junod A, Lambert AE, Orci L, Pictet R, Gonet AE, Renold AE (1967) Studies of the diabetogenic action of streptozotocin. Proc Soc Exp Biol Med 126:201\u2013205. https:\/\/doi.org\/10.3181\/00379727-126-32401","journal-title":"Proc Soc Exp Biol Med"},{"key":"1410_CR122","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.redox.2016.01.009","volume":"8","author":"PA Kakimoto","year":"2016","unstructured":"Kakimoto PA, Kowaltowski AJ (2016) Effects of high fat diets on rodent liver bioenergetics and oxidative imbalance. Redox Biol 8:216\u2013225. https:\/\/doi.org\/10.1016\/j.redox.2016.01.009","journal-title":"Redox Biol"},{"key":"1410_CR123","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9121259","author":"GJ Kang","year":"2020","unstructured":"Kang GJ, Kim EJ, Lee CH (2020) Therapeutic effects of specialized pro-resolving lipids mediators on cardiac fibrosis via NRF2 Activation. Antioxidants (basel). https:\/\/doi.org\/10.3390\/antiox9121259","journal-title":"Antioxidants (basel)"},{"key":"1410_CR124","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1111\/bph.15427","volume":"178","author":"A Kannt","year":"2021","unstructured":"Kannt A, Wohlfart P, Madsen AN, Veidal SS, Feigh M, Schmoll D (2021) Activation of thyroid hormone receptor-beta improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis. Br J Pharmacol 178:2412\u20132423. https:\/\/doi.org\/10.1111\/bph.15427","journal-title":"Br J Pharmacol"},{"key":"1410_CR125","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1136\/oem.58.11.747","volume":"58","author":"B Karlsson","year":"2001","unstructured":"Karlsson B, Knutsson A, Lindahl B (2001) Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27 485 people. Occup Environ Med 58:747\u2013752. https:\/\/doi.org\/10.1136\/oem.58.11.747","journal-title":"Occup Environ Med"},{"key":"1410_CR126","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41598-018-36862-7","volume":"9","author":"E Kawashita","year":"2019","unstructured":"Kawashita E, Ishihara K, Nomoto M, Taniguchi M, Akiba S (2019) A comparative analysis of hepatic pathological phenotypes in C57BL\/6J and C57BL\/6N mouse strains in non-alcoholic steatohepatitis models. Sci Rep 9:204. https:\/\/doi.org\/10.1038\/s41598-018-36862-7","journal-title":"Sci Rep"},{"key":"1410_CR127","doi-asserted-by":"publisher","DOI":"10.1021\/jm4019299","author":"MJ Kelly","year":"2014","unstructured":"Kelly MJ, Pietranico-Cole S, Larigan JD, Haynes N-E, Reynolds CH, Scott N, Vermeulen J, Dvorozniak M, Conde-Knape K, Huang K-S (2014). J Med Chem. https:\/\/doi.org\/10.1021\/jm4019299","journal-title":"J Med Chem"},{"key":"1410_CR128","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/hep.31713","volume":"74","author":"L Kennedy","year":"2021","unstructured":"Kennedy L, Meadows V, Sybenga A, Demieville J, Chen L, Hargrove L, Ekser B, Dar W, Ceci L, Kundu D, Kyritsi K, Pham L, Zhou T, Glaser S, Meng F, Alpini G, Francis H (2021) Mast cells promote nonalcoholic fatty liver disease phenotypes and microvesicular steatosis in mice fed a western diet. Hepatology 74:164\u2013182. https:\/\/doi.org\/10.1002\/hep.31713","journal-title":"Hepatology"},{"key":"1410_CR129","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.cmet.2017.07.009","volume":"26","author":"CW Kim","year":"2017","unstructured":"Kim CW, Addy C, Kusunoki J, Anderson NN, Deja S, Fu X, Burgess SC, Li C, Ruddy M, Chakravarthy M, Previs S, Milstein S, Fitzgerald K, Kelley DE, Horton JD (2017) Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation. Cell Metab 26:394-406.e6. https:\/\/doi.org\/10.1016\/j.cmet.2017.07.009","journal-title":"Cell Metab"},{"issue":"123\u2013131","key":"1410_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.08.014","volume":"16","author":"D Kim","year":"2018","unstructured":"Kim D, Kim W, Joo SK, Bae JM, Kim JH, Ahmed A (2018) Subclinical hypothyroidism and low-normal thyroid function are associated with nonalcoholic steatohepatitis and fibrosis. Clin Gastroenterol Hepatol 16(123\u2013131):e1. https:\/\/doi.org\/10.1016\/j.cgh.2017.08.014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1410_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-016-0477-5","volume":"16","author":"N Kishida","year":"2016","unstructured":"Kishida N, Matsuda S, Itano O, Shinoda M, Kitago M, Yagi H, Abe Y, Hibi T, Masugi Y, Aiura K (2016) Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine. BMC Gastroenterol 16:1\u201313. https:\/\/doi.org\/10.1186\/s12876-016-0477-5","journal-title":"BMC Gastroenterol"},{"key":"1410_CR132","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00795-013-0053-9","volume":"47","author":"T Klein","year":"2014","unstructured":"Klein T, Fujii M, Sandel J, Shibazaki Y, Wakamatsu K, Mark M, Yoneyama H (2014) Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis. Med Mol Morphol 47:137\u2013149. https:\/\/doi.org\/10.1007\/s00795-013-0053-9","journal-title":"Med Mol Morphol"},{"key":"1410_CR133","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.cld.2015.10.011","volume":"20","author":"DE Kleiner","year":"2016","unstructured":"Kleiner DE, Makhlouf HR (2016) Histology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults and children. Clin Liver Dis 20:293\u2013312. https:\/\/doi.org\/10.1016\/j.cld.2015.10.011","journal-title":"Clin Liver Dis"},{"issue":"1467\u20131477","key":"1410_CR134","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.06.045","volume":"137","author":"Y Kodama","year":"2009","unstructured":"Kodama Y, Kisseleva T, Iwaisako K, Miura K, Taura K, De Minicis S, Osterreicher CH, Schnabl B, Seki E, Brenner DA (2009) c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Gastroenterology 137(1467\u20131477):e5. https:\/\/doi.org\/10.1053\/j.gastro.2009.06.045","journal-title":"Gastroenterology"},{"key":"1410_CR135","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/hep.23797","volume":"52","author":"R Kohli","year":"2010","unstructured":"Kohli R, Kirby M, Xanthakos SA, Softic S, Feldstein AE, Saxena V, Tang PH, Miles L, Miles MV, Balistreri WF, Woods SC, Seeley RJ (2010) High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 52:934\u2013944. https:\/\/doi.org\/10.1002\/hep.23797","journal-title":"Hepatology"},{"key":"1410_CR136","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.phrs.2004.07.012","volume":"51","author":"BP Kota","year":"2005","unstructured":"Kota BP, Huang TH, Roufogalis BD (2005) An overview on biological mechanisms of PPARs. Pharmacol Res 51:85\u201394. https:\/\/doi.org\/10.1016\/j.phrs.2004.07.012","journal-title":"Pharmacol Res"},{"key":"1410_CR137","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/s0140-6736(87)91194-9","volume":"2","author":"B Kreymann","year":"1987","unstructured":"Kreymann B, Williams G, Ghatei MA, Bloom SR (1987) Glucagon-like peptide-1 7\u201336: a physiological incretin in man. Lancet 2:1300\u20131304. https:\/\/doi.org\/10.1016\/s0140-6736(87)91194-9","journal-title":"Lancet"},{"key":"1410_CR138","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-123364\/v1","author":"M Krishnappa","year":"2020","unstructured":"Krishnappa M, Patil K, Sharma S, Jain P, Trivedi P, Parmar D, Patel P (2020). Effectiveness of the PPAR Agonist Saroglitazar in Nonalcoholic Steatohepatitis: Positive Data from Preclinical & Clinical Studies. https:\/\/doi.org\/10.21203\/rs.3.rs-123364\/v1","journal-title":"Effectiveness of the PPAR Agonist Saroglitazar in Nonalcoholic Steatohepatitis: Positive Data from Preclinical & Clinical Studies"},{"key":"1410_CR139","doi-asserted-by":"publisher","first-page":"673","DOI":"10.4254\/wjh.v8.i16.673","volume":"8","author":"MN Kristiansen","year":"2016","unstructured":"Kristiansen MN, Veidal SS, Rigbolt KT, Tolbol KS, Roth JD, Jelsing J, Vrang N, Feigh M (2016) Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy. World J Hepatol 8:673\u2013684. https:\/\/doi.org\/10.4254\/wjh.v8.i16.673","journal-title":"World J Hepatol"},{"key":"1410_CR140","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/1440-1681.12102","volume":"40","author":"N Kubota","year":"2013","unstructured":"Kubota N, Kado S, Kano M, Masuoka N, Nagata Y, Kobayashi T, Miyazaki K, Ishikawa F (2013) A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice. Clin Exp Pharmacol Physiol 40:422\u2013430. https:\/\/doi.org\/10.1111\/1440-1681.12102","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1410_CR141","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.1038\/s41598-020-66458-z","volume":"10","author":"DP Kumar","year":"2020","unstructured":"Kumar DP, Caffrey R, Marioneaux J, Santhekadur PK, Bhat M, Alonso C, Koduru SV, Philip B, Jain MR, Giri SR, Bedossa P, Sanyal AJ (2020) The PPAR alpha\/gamma agonist saroglitazar improves insulin resistance and steatohepatitis in a diet induced animal model of nonalcoholic fatty liver disease. Sci Rep 10:9330. https:\/\/doi.org\/10.1038\/s41598-020-66458-z","journal-title":"Sci Rep"},{"key":"1410_CR142","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jhep.2008.01.026","volume":"48","author":"C Lackner","year":"2008","unstructured":"Lackner C, Gogg-Kamerer M, Zatloukal K, Stumptner C, Brunt EM, Denk H (2008) Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. J Hepatol 48:821\u2013828. https:\/\/doi.org\/10.1016\/j.jhep.2008.01.026","journal-title":"J Hepatol"},{"key":"1410_CR143","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jhep.2008.03.026","volume":"49","author":"CZ Larter","year":"2008","unstructured":"Larter CZ, Yeh MM, Williams J, Bell-Anderson KS, Farrell GC (2008) MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes. J Hepatol 49:407\u2013416. https:\/\/doi.org\/10.1016\/j.jhep.2008.03.026","journal-title":"J Hepatol"},{"key":"1410_CR144","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1111\/j.1440-1746.2009.05996.x","volume":"24","author":"CZ Larter","year":"2009","unstructured":"Larter CZ, Yeh MM, Van Rooyen DM, Teoh NC, Brooling J, Hou JY, Williams J, Clyne M, Nolan CJ, Farrell GC (2009) Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice. J Gastroenterol Hepatol 24:1658\u20131668. https:\/\/doi.org\/10.1111\/j.1440-1746.2009.05996.x","journal-title":"J Gastroenterol Hepatol"},{"key":"1410_CR145","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cld.2010.07.006","volume":"14","author":"K Law","year":"2010","unstructured":"Law K, Brunt EM (2010) Nonalcoholic fatty liver disease. Clin Liver Dis 14:591\u2013604. https:\/\/doi.org\/10.1016\/j.cld.2010.07.006","journal-title":"Clin Liver Dis"},{"key":"1410_CR146","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/s0168-8278(02)00102-2","volume":"37","author":"IA Leclercq","year":"2002","unstructured":"Leclercq IA, Farrell GC, Schriemer R, Robertson GR (2002) Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 37:206\u2013213. https:\/\/doi.org\/10.1016\/s0168-8278(02)00102-2","journal-title":"J Hepatol"},{"key":"1410_CR147","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/labinvest.3700489","volume":"87","author":"IA Leclercq","year":"2007","unstructured":"Leclercq IA, Lebrun VA, St\u00e4rkel P, Horsmans YJ (2007) Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPAR \u03b3 agonist pioglitazone. Lab Invest 87:56\u201365. https:\/\/doi.org\/10.1038\/labinvest.3700489","journal-title":"Lab Invest"},{"key":"1410_CR148","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12272-020-01299-y","volume":"44","author":"CH Lee","year":"2021","unstructured":"Lee CH (2021) Role of specialized pro-resolving lipid mediators and their receptors in virus infection: a promising therapeutic strategy for SARS-CoV-2 cytokine storm. Arch Pharm Res 44:84\u201398. https:\/\/doi.org\/10.1007\/s12272-020-01299-y","journal-title":"Arch Pharm Res"},{"key":"1410_CR149","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/379632a0","volume":"379","author":"GH Lee","year":"1996","unstructured":"Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632\u2013635. https:\/\/doi.org\/10.1038\/379632a0","journal-title":"Nature"},{"key":"1410_CR150","doi-asserted-by":"publisher","DOI":"10.1172\/jci154333","author":"S Lee","year":"2022","unstructured":"Lee S, Usman TO, Yamauchi J, Chhetri G, Wang X, Coudriet GM, Zhu C, Gao J, Mcconnell R, Krantz K, Rajasundaram D, Singh S, Piganelli J, Ostrowska A, Soto-Gutierrez A, Monga SP, Singhi AD, Muzumdar R, Tsung A, Dong HH (2022) Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis. J Clin Invest. https:\/\/doi.org\/10.1172\/jci154333","journal-title":"J Clin Invest"},{"key":"1410_CR151","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1172\/JCI65179","volume":"122","author":"JZ Li","year":"2012","unstructured":"Li JZ, Huang Y, Karaman R, Ivanova PT, Brown HA, Roddy T, Castro-Perez J, Cohen JC, Hobbs HH (2012) Chronic overexpression of PNPLA3 I148M in mouse liver causes hepatic steatosis. J Clin Investig 122:4130\u20134144. https:\/\/doi.org\/10.1172\/JCI65179","journal-title":"J Clin Investig"},{"key":"1410_CR152","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F, Li X, Chien N, Wei M, Ogawa E, Zhao C, Wu X, Stave CD, Henry L, Barnett S, Takahashi H, Furusyo N, Eguchi Y, Hsu YC, Lee TY, Ren W, Qin C, Jun DW, Toyoda H, Wong VW, Cheung R, Zhu Q, Nguyen MH (2019) Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 4:389\u2013398. https:\/\/doi.org\/10.1016\/S2468-1253(19)30039-1","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1410_CR153","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/liv.14428","volume":"40","author":"X Li","year":"2020","unstructured":"Li X, Wang TX, Huang X, Li Y, Sun T, Zang S, Guan KL, Xiong Y, Liu J, Yuan HX (2020) Targeting ferroptosis alleviates methionine-choline deficient (MCD)-diet induced NASH by suppressing liver lipotoxicity. Liver Int 40:1378\u20131394. https:\/\/doi.org\/10.1111\/liv.14428","journal-title":"Liver Int"},{"key":"1410_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111587","volume":"139","author":"C Li","year":"2021","unstructured":"Li C, Zhou W, Li M, Shu X, Zhang L, Ji G (2021) Salvia-Nelumbinis naturalis extract protects mice against MCD diet-induced steatohepatitis via activation of colonic FXR-FGF15 pathway. Biomed Pharmacother 139:111587. https:\/\/doi.org\/10.1016\/j.biopha.2021.111587","journal-title":"Biomed Pharmacother"},{"key":"1410_CR155","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","volume":"7","author":"JS Lim","year":"2010","unstructured":"Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH (2010) The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol 7:251\u2013264. https:\/\/doi.org\/10.1038\/nrgastro.2010.41","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1410_CR156","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1100\/tsw.2007.117","volume":"7","author":"P Lindstrom","year":"2007","unstructured":"Lindstrom P (2007) The physiology of obese-hyperglycemic mice [ob\/ob mice]. ScientificWorldJournal 7:666\u2013685. https:\/\/doi.org\/10.1100\/tsw.2007.117","journal-title":"ScientificWorldJournal"},{"key":"1410_CR157","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1073\/pnas.0630588100","volume":"100","author":"LL Listenberger","year":"2003","unstructured":"Listenberger LL, Han X, Lewis SE, Cases S, Farese RV Jr, Ory DS, Schaffer JE (2003) Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 100:3077\u20133082. https:\/\/doi.org\/10.1073\/pnas.0630588100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1410_CR158","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1749-6632.2009.05131.x","volume":"1183","author":"FT Liu","year":"2010","unstructured":"Liu FT, Rabinovich GA (2010) Galectins: regulators of acute and chronic inflammation. Ann N Y Acad Sci 1183:158\u2013182. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05131.x","journal-title":"Ann N Y Acad Sci"},{"key":"1410_CR159","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/hep.25539","volume":"55","author":"R Lomonaco","year":"2012","unstructured":"Lomonaco R, Ortiz-Lopez C, Orsak B, Webb A, Hardies J, Darland C, Finch J, Gastaldelli A, Harrison S, Tio F, Cusi K (2012) Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 55:1389\u20131397. https:\/\/doi.org\/10.1002\/hep.25539","journal-title":"Hepatology"},{"key":"1410_CR160","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","volume":"70","author":"A Lonardo","year":"2019","unstructured":"Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, Abdelmalek MF, Suzuki A (2019) Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps. Hepatology 70:1457\u20131469. https:\/\/doi.org\/10.1002\/hep.30626","journal-title":"Hepatology"},{"key":"1410_CR161","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/gutjnl-2012-303179","volume":"63","author":"C L\u00f3pez-Vicario","year":"2014","unstructured":"L\u00f3pez-Vicario C, Gonz\u00e1lez-P\u00e9riz A, Rius B, Mor\u00e1n-Salvador E, Garc\u00eda-Alonso V, Lozano JJ, Bataller R, Cof\u00e1n M, Kang JX, Arroyo V, Cl\u00e0ria J, Titos E (2014) Molecular interplay between \u03945\/\u03946 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis. Gut 63:344\u2013355. https:\/\/doi.org\/10.1136\/gutjnl-2012-303179","journal-title":"Gut"},{"key":"1410_CR162","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1586\/egh.11.16","volume":"5","author":"MV Machado","year":"2011","unstructured":"Machado MV, Cortez-Pinto H (2011) Cell death and nonalcoholic steatohepatitis: where is ballooning relevant? Expert Rev Gastroenterol Hepatol 5:213\u2013222. https:\/\/doi.org\/10.1586\/egh.11.16","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1410_CR163","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127991","volume":"10","author":"MV Machado","year":"2015","unstructured":"Machado MV, Michelotti GA, Xie G, De Almeida TP, Boursier J, Bohnic B, Guy CD, Diehl AM (2015) Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. PLoS ONE 10:e0127991. https:\/\/doi.org\/10.1371\/journal.pone.0127991","journal-title":"PLoS ONE"},{"key":"1410_CR164","doi-asserted-by":"publisher","first-page":"12093","DOI":"10.1074\/jbc.M510660200","volume":"281","author":"H Malhi","year":"2006","unstructured":"Malhi H, Bronk SF, Werneburg NW, Gores GJ (2006) Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J Biol Chem 281:12093\u201312101. https:\/\/doi.org\/10.1074\/jbc.M510660200","journal-title":"J Biol Chem"},{"key":"1410_CR165","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cmet.2006.07.006","volume":"4","author":"M Mari","year":"2006","unstructured":"Mari M, Caballero F, Colell A, Morales A, Caballeria J, Fernandez A, Enrich C, Fernandez-Checa JC, Garcia-Ruiz C (2006) Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab 4:185\u2013198. https:\/\/doi.org\/10.1016\/j.cmet.2006.07.006","journal-title":"Cell Metab"},{"key":"1410_CR166","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158817","volume":"11","author":"V Marin","year":"2016","unstructured":"Marin V, Rosso N, Dal Ben M, Raseni A, Boschelle M, Degrassi C, Nemeckova I, Nachtigal P, Avellini C, Tiribelli C, Gazzin S (2016) An animal model for the juvenile non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. PLoS ONE 11:e0158817. https:\/\/doi.org\/10.1371\/journal.pone.0158817","journal-title":"PLoS ONE"},{"key":"1410_CR167","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","volume":"68","author":"F Marra","year":"2018","unstructured":"Marra F, Svegliati-Baroni G (2018) Lipotoxicity and the gut-liver axis in NASH pathogenesis. J Hepatol 68:280\u2013295. https:\/\/doi.org\/10.1016\/j.jhep.2017.11.014","journal-title":"J Hepatol"},{"key":"1410_CR168","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1096\/fj.201600859R","volume":"31","author":"L Mart\u00ednez-Fern\u00e1ndez","year":"2017","unstructured":"Mart\u00ednez-Fern\u00e1ndez L, Gonz\u00e1lez-Muniesa P, Laiglesia LM, S\u00e1inz N, Prieto-Hontoria PL, Escot\u00e9 X, Odriozola L, Corrales FJ, Arbones-Mainar JM, Mart\u00ednez JA, Moreno-Aliaga MJ (2017) Maresin 1 improves insulin sensitivity and attenuates adipose tissue inflammation in ob\/ob and diet-induced obese mice. Faseb j 31:2135\u20132145. https:\/\/doi.org\/10.1096\/fj.201600859R","journal-title":"Faseb j"},{"key":"1410_CR169","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3945\/an.113.004648","volume":"4","author":"DG Mashek","year":"2013","unstructured":"Mashek DG (2013) Hepatic fatty acid trafficking: multiple forks in the road. Adv Nutr 4:697\u2013710. https:\/\/doi.org\/10.3945\/an.113.004648","journal-title":"Adv Nutr"},{"key":"1410_CR170","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jnutbio.2018.02.003","volume":"55","author":"R Mastrocola","year":"2018","unstructured":"Mastrocola R, Ferrocino I, Liberto E, Chiazza F, Cento AS, Collotta D, Querio G, Nigro D, Bitonto V, Cutrin JC, Rantsiou K, Durante M, Masini E, Aragno M, Cordero C, Cocolin L, Collino M (2018) Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study. J Nutr Biochem 55:185\u2013199. https:\/\/doi.org\/10.1016\/j.jnutbio.2018.02.003","journal-title":"J Nutr Biochem"},{"key":"1410_CR171","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","volume":"368","author":"T Matsubara","year":"2013","unstructured":"Matsubara T, Li F, Gonzalez FJ (2013) FXR signaling in the enterohepatic system. Mol Cell Endocrinol 368:17\u201329. https:\/\/doi.org\/10.1016\/j.mce.2012.05.004","journal-title":"Mol Cell Endocrinol"},{"key":"1410_CR172","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/iep.12008","volume":"94","author":"M Matsumoto","year":"2013","unstructured":"Matsumoto M, Hada N, Sakamaki Y, Uno A, Shiga T, Tanaka C, Ito T, Katsume A, Sudoh M (2013) An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis. Int J Exp Pathol 94:93\u2013103. https:\/\/doi.org\/10.1111\/iep.12008","journal-title":"Int J Exp Pathol"},{"key":"1410_CR173","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/hep.21874","volume":"46","author":"N Matsuzawa","year":"2007","unstructured":"Matsuzawa N, Takamura T, Kurita S, Misu H, Ota T, Ando H, Yokoyama M, Honda M, Zen Y, Nakanuma Y, Miyamoto K, Kaneko S (2007) Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 46:1392\u20131403. https:\/\/doi.org\/10.1002\/hep.21874","journal-title":"Hepatology"},{"key":"1410_CR174","doi-asserted-by":"publisher","first-page":"754S","DOI":"10.1093\/ajcn\/58.5.754S","volume":"58","author":"PA Mayes","year":"1993","unstructured":"Mayes PA (1993) Intermediary metabolism of fructose. Am J Clin Nutr 58:754S-765S. https:\/\/doi.org\/10.1093\/ajcn\/58.5.754S","journal-title":"Am J Clin Nutr"},{"key":"1410_CR175","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jnutbio.2014.11.002","volume":"26","author":"JE Mells","year":"2015","unstructured":"Mells JE, Fu PP, Kumar P, Smith T, Karpen SJ, Anania FA (2015) Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis. J Nutr Biochem 26:285\u2013292. https:\/\/doi.org\/10.1016\/j.jnutbio.2014.11.002","journal-title":"J Nutr Biochem"},{"issue":"323\u201334","key":"1410_CR176","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.03.052","volume":"139","author":"K Miura","year":"2010","unstructured":"Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, Olefsky JM, Brenner DA, Seki E (2010) Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology 139(323\u201334):e7. https:\/\/doi.org\/10.1053\/j.gastro.2010.03.052","journal-title":"Gastroenterology"},{"key":"1410_CR177","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/hep.26081","volume":"57","author":"K Miura","year":"2013","unstructured":"Miura K, Yang L, Van Rooijen N, Brenner DA, Ohnishi H, Seki E (2013) Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. Hepatology 57:577\u2013589. https:\/\/doi.org\/10.1002\/hep.26081","journal-title":"Hepatology"},{"key":"1410_CR178","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/cts.13235","volume":"15","author":"MB M\u00f8llerh\u00f8j","year":"2022","unstructured":"M\u00f8llerh\u00f8j MB, Veidal SS, Thrane KT, Or\u00f3 D, Overgaard A, Salinas CG, Madsen MR, Pfisterer L, Vyberg M, Simon E (2022) Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH. Clin Transl Sci 15:1167\u20131186. https:\/\/doi.org\/10.1111\/cts.13235","journal-title":"Clin Transl Sci"},{"key":"1410_CR179","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9080759","author":"M Monserrat-Mesquida","year":"2020","unstructured":"Monserrat-Mesquida M, Quetglas-Llabr\u00e9s M, Abbate M, Montemayor S, Mascar\u00f3 CM, Casares M, Tejada S, Abete I, Zulet MA, Tur JA, Mart\u00ednez JA, Sureda A (2020) Oxidative stress and pro-inflammatory status in patients with non-alcoholic fatty liver disease. Antioxidants (basel). https:\/\/doi.org\/10.3390\/antiox9080759","journal-title":"Antioxidants (basel)"},{"key":"1410_CR180","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3389\/fphys.2018.00132","volume":"9","author":"MC Morrison","year":"2018","unstructured":"Morrison MC, Kleemann R, Van Koppen A, Hanemaaijer R, Verschuren L (2018a) Key inflammatory processes in human NASH are reflected in Ldlr\u2212\/\u2212. Leiden mice: A translational gene profiling study. Front Physiol 9:132","journal-title":"Front Physiol"},{"key":"1410_CR181","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/hep4.1270","volume":"2","author":"MC Morrison","year":"2018","unstructured":"Morrison MC, Verschuren L, Salic K, Verheij J, Menke A, Wielinga PY, Iruarrizaga-Lejarreta M, Gole L, Yu WM, Turner S (2018b) Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr-\/-. Leiden Mice Hepatology Communications 2:1513\u20131532","journal-title":"Leiden Mice Hepatology Communications"},{"key":"1410_CR182","doi-asserted-by":"publisher","first-page":"85832","DOI":"10.18632\/oncotarget.11037","volume":"7","author":"A Mteyrek","year":"2016","unstructured":"Mteyrek A, Filipski E, Guettier C, Okyar A, L\u00e9vi F (2016) Clock gene Per2 as a controller of liver carcinogenesis. Oncotarget 7:85832\u201385847. https:\/\/doi.org\/10.18632\/oncotarget.11037","journal-title":"Oncotarget"},{"key":"1410_CR183","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.tips.2018.01.003","volume":"39","author":"G Musso","year":"2018","unstructured":"Musso G, Gambino R, Cassader M, Paschetta E, Sircana A (2018) Specialized proresolving mediators: enhancing nonalcoholic steatohepatitis and fibrosis resolution. Trends Pharmacol Sci 39:387\u2013401. https:\/\/doi.org\/10.1016\/j.tips.2018.01.003","journal-title":"Trends Pharmacol Sci"},{"key":"1410_CR184","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/j.1349-7006.1990.tb02515.x","volume":"81","author":"D Nakae","year":"1990","unstructured":"Nakae D, Yoshiji H, Maruyama H, Kinugasa T, Denda A, Konishi Y (1990) Production of both 8-hydroxydeoxyguanosine in liver DNA and \u03b3-glutamyltransferase-positive hepatocellular lesions in rats given a choline-deficient, l-amino acid-defined diet. Jpn J Cancer Res 81:1081\u20131084. https:\/\/doi.org\/10.1111\/j.1349-7006.1990.tb02515.x","journal-title":"Jpn J Cancer Res"},{"key":"1410_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101102","volume":"46","author":"MA Nauck","year":"2021","unstructured":"Nauck MA, Quast DR, Wefers J, Meier JJ (2021) GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art. Mol Metab 46:101102. https:\/\/doi.org\/10.1016\/j.molmet.2020.101102","journal-title":"Mol Metab"},{"key":"1410_CR186","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1023\/a:1012338828418","volume":"46","author":"V Nehra","year":"2001","unstructured":"Nehra V, Angulo P, Buchman AL, Lindor KD (2001) Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci 46:2347\u20132352. https:\/\/doi.org\/10.1023\/a:1012338828418","journal-title":"Dig Dis Sci"},{"key":"1410_CR187","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/hep.23719","volume":"52","author":"BA Neuschwander-Tetri","year":"2010","unstructured":"Neuschwander-Tetri BA (2010) Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52:774\u2013788. https:\/\/doi.org\/10.1002\/hep.23719","journal-title":"Hepatology"},{"key":"1410_CR188","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","volume":"384","author":"PN Newsome","year":"2021","unstructured":"Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, Sanyal AJ, Sejling AS, Harrison SA, Investigators NN (2021) A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med 384:1113\u20131124. https:\/\/doi.org\/10.1056\/NEJMoa2028395","journal-title":"N Engl J Med"},{"key":"1410_CR189","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13105-020-00777-7","volume":"77","author":"XX Ni","year":"2021","unstructured":"Ni XX, Li XY, Wang Q, Hua J (2021) Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-\u03b21\/Smad signaling pathway. J Physiol Biochem 77:35\u201345. https:\/\/doi.org\/10.1007\/s13105-020-00777-7","journal-title":"J Physiol Biochem"},{"key":"1410_CR190","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1538\/expanim.56.263","volume":"56","author":"S Nishikawa","year":"2007","unstructured":"Nishikawa S, Yasoshima A, Doi K, Nakayama H, Uetsuka K (2007) Involvement of sex, strain and age factors in high fat diet-induced obesity in C57BL\/6J and BALB\/cA mice. Exp Anim 56:263\u2013272. https:\/\/doi.org\/10.1538\/expanim.56.263","journal-title":"Exp Anim"},{"key":"1410_CR191","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0163-7827(94)00010-j","volume":"34","author":"JM Ntambi","year":"1995","unstructured":"Ntambi JM (1995) The regulation of stearoyl-CoA desaturase (SCD). Prog Lipid Res 34:139\u2013150. https:\/\/doi.org\/10.1016\/0163-7827(94)00010-j","journal-title":"Prog Lipid Res"},{"key":"1410_CR192","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jhep.2010.02.029","volume":"53","author":"N Obara","year":"2010","unstructured":"Obara N, Fukushima K, Ueno Y, Wakui Y, Kimura O, Tamai K, Kakazu E, Inoue J, Kondo Y, Ogawa N, Sato K, Tsuduki T, Ishida K, Shimosegawa T (2010) Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice. J Hepatol 53:326\u2013334. https:\/\/doi.org\/10.1016\/j.jhep.2010.02.029","journal-title":"J Hepatol"},{"key":"1410_CR193","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","volume":"48","author":"X Ouyang","year":"2008","unstructured":"Ouyang X, Cirillo P, Sautin Y, Mccall S, Bruchette JL, Diehl AM, Johnson RJ, Abdelmalek MF (2008) Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48:993\u2013999. https:\/\/doi.org\/10.1016\/j.jhep.2008.02.011","journal-title":"J Hepatol"},{"key":"1410_CR194","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/hep.26440","volume":"58","author":"ND Palmer","year":"2013","unstructured":"Palmer ND, Musani SK, Yerges-Armstrong LM, Feitosa MF, Bielak LF, Hernaez R, Kahali B, Carr JJ, Harris TB, Jhun MA, Kardia SL, Langefeld CD, Mosley TH Jr, Norris JM, Smith AV, Taylor HA, Wagenknecht LE, Liu J, Borecki IB, Peyser PA, Speliotes EK (2013) Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent. Hepatology 58:966\u2013975. https:\/\/doi.org\/10.1002\/hep.26440","journal-title":"Hepatology"},{"key":"1410_CR195","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.fct.2015.03.029","volume":"80","author":"V Pardo","year":"2015","unstructured":"Pardo V, Gonzalez-Rodriguez A, Muntane J, Kozma SC, Valverde AM (2015) Role of hepatocyte S6K1 in palmitic acid-induced endoplasmic reticulum stress, lipotoxicity, insulin resistance and in oleic acid-induced protection. Food Chem Toxicol 80:298\u2013309. https:\/\/doi.org\/10.1016\/j.fct.2015.03.029","journal-title":"Food Chem Toxicol"},{"key":"1410_CR196","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","volume":"284","author":"DJ Parks","year":"1999","unstructured":"Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM (1999) Bile acids: natural ligands for an orphan nuclear receptor. Science 284:1365\u20131368. https:\/\/doi.org\/10.1126\/science.284.5418.1365","journal-title":"Science"},{"key":"1410_CR197","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1021\/jm049904b","volume":"47","author":"R Pellicciari","year":"2004","unstructured":"Pellicciari R, Costantino G, Camaioni E, Sadeghpour BM, Entrena A, Willson TM, Fiorucci S, Clerici C, Gioiello A (2004) Bile acid derivatives as ligands of the farnesoid X receptor. Synthesis, evaluation, and structure\u2212 activity relationship of a series of body and side chain modified analogues of chenodeoxycholic acid. J Med Chem 47:4559\u20134569. https:\/\/doi.org\/10.1021\/jm049904b","journal-title":"J Med Chem"},{"key":"1410_CR198","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126332","author":"N Perakakis","year":"2021","unstructured":"Perakakis N, Chrysafi P, Feigh M, Veidal SS, Mantzoros CS (2021a) Empagliflozin improves metabolic and hepatic outcomes in a non-diabetic obese biopsy-proven mouse model of advanced NASH. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22126332","journal-title":"Int J Mol Sci"},{"key":"1410_CR199","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1111\/liv.14888","volume":"41","author":"N Perakakis","year":"2021","unstructured":"Perakakis N, Stefanakis K, Feigh M, Veidal SS, Mantzoros CS (2021b) Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis. Liver Int 41:1853\u20131866. https:\/\/doi.org\/10.1111\/liv.14888","journal-title":"Liver Int"},{"key":"1410_CR200","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.bbalip.2018.06.018","volume":"1864","author":"P Pingitore","year":"2019","unstructured":"Pingitore P, Romeo S (2019) The role of PNPLA3 in health and disease. Biochim Biophys Acta Mol Cell Biol Lipids 1864:900\u2013906. https:\/\/doi.org\/10.1016\/j.bbalip.2018.06.018","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"1410_CR201","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cmet.2011.03.019","volume":"13","author":"MJ Potthoff","year":"2011","unstructured":"Potthoff MJ, Boney-Montoya J, Choi M, He T, Sunny NE, Satapati S, Suino-Powell K, Xu HE, Gerard RD, Finck BN, Burgess SC, Mangelsdorf DJ, Kliewer SA (2011) FGF15\/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1\u03b1 pathway. Cell Metab 13:729\u2013738. https:\/\/doi.org\/10.1016\/j.cmet.2011.03.019","journal-title":"Cell Metab"},{"key":"1410_CR202","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jacbts.2018.09.004","volume":"3","author":"G Rakipovski","year":"2018","unstructured":"Rakipovski G, Rolin B, N\u00f8hr J, Klewe I, Frederiksen KS, Augustin R, Hecksher-S\u00f8rensen J, Ingvorsen C, Polex-Wolf J, Knudsen LB (2018) The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE\u2212\/\u2212 and LDLr\u2212\/\u2212 mice by a mechanism that includes inflammatory pathways. JACC Basic Trans Sci 3:844\u2013857. https:\/\/doi.org\/10.1016\/j.jacbts.2018.09.004","journal-title":"JACC Basic Trans Sci"},{"key":"1410_CR203","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/s41591-021-01495-3","volume":"27","author":"V Ratziu","year":"2021","unstructured":"Ratziu V, De Guevara L, Safadi R, Poordad F, Fuster F, Flores-Figueroa J, Arrese M, Fracanzani AL, Ben Bashat D, Lackner K, Gorfine T, Kadosh S, Oren R, Halperin M, Hayardeny L, Loomba R, Friedman S, Group AIS, Sanyal AJ (2021) Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial. Nat Med 27:1825\u20131835. https:\/\/doi.org\/10.1038\/s41591-021-01495-3","journal-title":"Nat Med"},{"key":"1410_CR204","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408449309104072","volume":"23","author":"JL Raucy","year":"1993","unstructured":"Raucy JL, Kraner JC, Lasker JM (1993) Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit Rev Toxicol 23:1\u201320. https:\/\/doi.org\/10.3109\/10408449309104072","journal-title":"Crit Rev Toxicol"},{"key":"1410_CR205","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1463-1326.1999.00014.x","volume":"1","author":"MJ Reed","year":"1999","unstructured":"Reed MJ, Scribner KA (1999) In-vivo and in-vitro models of type 2 diabetes in pharmaceutical drug discovery. Diabetes Obes Metab 1:75\u201386. https:\/\/doi.org\/10.1046\/j.1463-1326.1999.00014.x","journal-title":"Diabetes Obes Metab"},{"key":"1410_CR206","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1007\/s10620-016-4085-6","volume":"61","author":"HL Reeves","year":"2016","unstructured":"Reeves HL, Zaki MY, Day CP (2016) Hepatocellular carcinoma in obesity, type 2 diabetes, and NAFLD. Dig Dis Sci 61:1234\u20131245. https:\/\/doi.org\/10.1007\/s10620-016-4085-6","journal-title":"Dig Dis Sci"},{"key":"1410_CR207","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.1038\/s41598-020-63579-3","volume":"10","author":"M R\u00e9gnier","year":"2020","unstructured":"R\u00e9gnier M, Polizzi A, Smati S, Lukowicz C, Fougerat A, Lippi Y, Fouch\u00e9 E, Lasserre F, Naylies C, B\u00e9touli\u00e8res C, Barquissau V, Mouisel E, Bertrand-Michel J, Batut A, Saati TA, Canlet C, Tremblay-Franco M, Ellero-Simatos S, Langin D, Postic C, Wahli W, Loiseau N, Guillou H, Montagner A (2020) Hepatocyte-specific deletion of Ppar\u03b1 promotes NAFLD in the context of obesity. Sci Rep 10:6489. https:\/\/doi.org\/10.1038\/s41598-020-63579-3","journal-title":"Sci Rep"},{"key":"1410_CR208","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1096\/fj.13-235614","volume":"28","author":"B Rius","year":"2014","unstructured":"Rius B, Titos E, Mor\u00e1n-Salvador E, L\u00f3pez-Vicario C, Garc\u00eda-Alonso V, Gonz\u00e1lez-P\u00e9riz A, Arroyo V, Cl\u00e0ria J (2014) Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. Faseb j 28:836\u2013848. https:\/\/doi.org\/10.1096\/fj.13-235614","journal-title":"Faseb j"},{"key":"1410_CR209","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1194\/jlr.M600198-JLR200","volume":"47","author":"G Rizki","year":"2006","unstructured":"Rizki G, Arnaboldi L, Gabrielli B, Yan J, Lee GS, Ng RK, Turner SM, Badger TM, Pitas RE, Maher JJ (2006) Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. J Lipid Res 47:2280\u20132290. https:\/\/doi.org\/10.1194\/jlr.M600198-JLR200","journal-title":"J Lipid Res"},{"key":"1410_CR210","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40:1461\u20131465. https:\/\/doi.org\/10.1038\/ng.257","journal-title":"Nat Genet"},{"key":"1410_CR211","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1136\/gut.27.10.1161","volume":"27","author":"JJ Rumessen","year":"1986","unstructured":"Rumessen JJ, Gudmand-Hoyer E (1986) Absorption capacity of fructose in healthy adults. Comparison with sucrose and its constituent monosaccharides. Gut 27:1161\u20131168. https:\/\/doi.org\/10.1136\/gut.27.10.1161","journal-title":"Gut"},{"issue":"2085\u201391","key":"1410_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.04.038","volume":"12","author":"Safadi, R., Konikoff, F. M., Mahamid, M., Zelber-Sagi, S., Halpern, M., Gilat, T., Oren, R., and Group, F","year":"2014","unstructured":"Safadi, R., Konikoff, F. M., Mahamid, M., Zelber-Sagi, S., Halpern, M., Gilat, T., Oren, R., and Group, F (2014) The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 12(2085\u201391):e1. https:\/\/doi.org\/10.1016\/j.cgh.2014.04.038","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1410_CR213","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00002.2004a","author":"A Sahai","year":"2004","unstructured":"Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF (2004a) Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am J Physiol-Gastrointestinal Liver Physiol. https:\/\/doi.org\/10.1152\/ajpgi.00002.2004a","journal-title":"Am J Physiol-Gastrointestinal Liver Physiol"},{"key":"1410_CR214","doi-asserted-by":"publisher","first-page":"G1035","DOI":"10.1152\/ajpgi.00199.2004","volume":"287","author":"A Sahai","year":"2004","unstructured":"Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whitington PF (2004b) Obese and diabetic db\/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 287:G1035\u2013G1043. https:\/\/doi.org\/10.1152\/ajpgi.00199.2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1410_CR215","doi-asserted-by":"publisher","first-page":"12466","DOI":"10.1038\/srep12466","volume":"5","author":"K Saito","year":"2015","unstructured":"Saito K, Uebanso T, Maekawa K, Ishikawa M, Taguchi R, Nammo T, Nishimaki-Mogami T, Udagawa H, Fujii M, Shibazaki Y, Yoneyama H, Yasuda K, Saito Y (2015) Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis. Sci Rep 5:12466. https:\/\/doi.org\/10.1038\/srep12466","journal-title":"Sci Rep"},{"key":"1410_CR216","doi-asserted-by":"publisher","first-page":"791","DOI":"10.33549\/physiolres.933592","volume":"66","author":"T Saito","year":"2017","unstructured":"Saito T, Muramatsu M, Ishii Y, Saigo Y, Konuma T, Toriniwa Y, Miyajima K, Ohta T (2017) Pathophysiological analysis of the progression of hepatic lesions in STAM mice. Physiol Res 66:791\u2013799. https:\/\/doi.org\/10.33549\/physiolres.933592","journal-title":"Physiol Res"},{"key":"1410_CR217","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/574832","volume":"2015","author":"SC Sanches","year":"2015","unstructured":"Sanches SC, Ramalho LN, Augusto MJ, Da Silva DM, Ramalho FS (2015) Nonalcoholic steatohepatitis: a search for factual animal models. Biomed Res Int 2015:574832. https:\/\/doi.org\/10.1155\/2015\/574832","journal-title":"Biomed Res Int"},{"key":"1410_CR218","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/brv.12178","volume":"91","author":"FW Sanders","year":"2016","unstructured":"Sanders FW, Griffin JL (2016) De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biol Rev Camb Philos Soc 91:452\u2013468. https:\/\/doi.org\/10.1111\/brv.12178","journal-title":"Biol Rev Camb Philos Soc"},{"key":"1410_CR219","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/hep.31808","volume":"74","author":"A Sano","year":"2021","unstructured":"Sano A, Kakazu E, Hamada S, Inoue J, Ninomiya M, Iwata T, Tsuruoka M, Sato K, Masamune A (2021) Steatotic hepatocytes release mature VLDL through methionine and tyrosine metabolism in a keap1-Nrf2\u2013dependent manner. Hepatology 74:1271\u20131286. https:\/\/doi.org\/10.1002\/hep.31808","journal-title":"Hepatology"},{"key":"1410_CR220","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/hep.24806","volume":"55","author":"N Santoro","year":"2012","unstructured":"Santoro N, Zhang CK, Zhao H, Pakstis AJ, Kim G, Kursawe R, Dykas DJ, Bale AE, Giannini C, Pierpont B (2012) Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents. Hepatology 55:781\u2013789. https:\/\/doi.org\/10.1002\/hep.24806","journal-title":"Hepatology"},{"key":"1410_CR221","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1172\/JCI82204","volume":"125","author":"S Satapati","year":"2015","unstructured":"Satapati S, Kucejova B, Duarte JA, Fletcher JA, Reynolds L, Sunny NE, He T, Nair LA, Livingston KA, Fu X, Merritt ME, Sherry AD, Malloy CR, Shelton JM, Lambert J, Parks EJ, Corbin I, Magnuson MA, Browning JD, Burgess SC (2015) Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. J Clin Invest 125:4447\u20134462. https:\/\/doi.org\/10.1172\/JCI82204","journal-title":"J Clin Invest"},{"key":"1410_CR222","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/ejcn.2011.3","volume":"65","author":"E Sathiaraj","year":"2011","unstructured":"Sathiaraj E, Chutke M, Reddy MY, Pratap N, Rao PN, Reddy DN, Raghunath M (2011) A case-control study on nutritional risk factors in non-alcoholic fatty liver disease in Indian population. Eur J Clin Nutr 65:533\u2013537. https:\/\/doi.org\/10.1038\/ejcn.2011.3","journal-title":"Eur J Clin Nutr"},{"key":"1410_CR223","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/hep.25789","volume":"57","author":"C Savard","year":"2013","unstructured":"Savard C, Tartaglione EV, Kuver R, Haigh WG, Farrell GC, Subramanian S, Chait A, Yeh MM, Quinn LS, Ioannou GN (2013) Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. Hepatology 57:81\u201392. https:\/\/doi.org\/10.1002\/hep.25789","journal-title":"Hepatology"},{"key":"1410_CR224","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/0023677215571192","volume":"49","author":"D Scholten","year":"2015","unstructured":"Scholten D, Trebicka J, Liedtke C, Weiskirchen R (2015) The carbon tetrachloride model in mice. Lab Anim 49:4\u201311. https:\/\/doi.org\/10.1177\/0023677215571192","journal-title":"Lab Anim"},{"key":"1410_CR225","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.27332","volume":"61","author":"E Seki","year":"2015","unstructured":"Seki E, Schwabe RF (2015) Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology 61:1066\u20131079. https:\/\/doi.org\/10.1002\/hep.27332","journal-title":"Hepatology"},{"key":"1410_CR226","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.toxlet.2019.01.001","volume":"304","author":"L Sharma","year":"2019","unstructured":"Sharma L, Gupta D, Abdullah ST (2019) Thioacetamide potentiates high cholesterol and high fat diet induced steato-hepatitic changes in livers of C57BL\/6J mice: A novel eight weeks model of fibrosing NASH. Toxicol Lett 304:21\u201329. https:\/\/doi.org\/10.1016\/j.toxlet.2019.01.001","journal-title":"Toxicol Lett"},{"key":"1410_CR227","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025231","volume":"6","author":"S Shimba","year":"2011","unstructured":"Shimba S, Ogawa T, Hitosugi S, Ichihashi Y, Nakadaira Y, Kobayashi M, Tezuka M, Kosuge Y, Ishige K, Ito Y, Komiyama K, Okamatsu-Ogura Y, Kimura K, Saito M (2011) Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation. PLoS ONE 6:e25231. https:\/\/doi.org\/10.1371\/journal.pone.0025231","journal-title":"PLoS ONE"},{"key":"1410_CR228","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jhep.2019.10.006","volume":"72","author":"MS Siddiqui","year":"2020","unstructured":"Siddiqui MS, Van Natta ML, Connelly MA, Vuppalanchi R, Neuschwander-Tetri BA, Tonascia J, Guy C, Loomba R, Dasarathy S, Wattacheril J, Chalasani N, Sanyal AJ, Nash CRN (2020) Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis. J Hepatol 72:25\u201333. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.006","journal-title":"J Hepatol"},{"key":"1410_CR229","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrendo.2018.10","volume":"14","author":"RA Sinha","year":"2018","unstructured":"Sinha RA, Singh BK, Yen PM (2018) Direct effects of thyroid hormones on hepatic lipid metabolism. Nat Rev Endocrinol 14:259\u2013269. https:\/\/doi.org\/10.1038\/nrendo.2018.10","journal-title":"Nat Rev Endocrinol"},{"key":"1410_CR230","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1089\/thy.2018.0664","volume":"29","author":"RA Sinha","year":"2019","unstructured":"Sinha RA, Bruinstroop E, Singh BK, Yen PM (2019) Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid hormones, metabolites, and agonists. Thyroid 29:1173\u20131191. https:\/\/doi.org\/10.1089\/thy.2018.0664","journal-title":"Thyroid"},{"issue":"735\u2013753","key":"1410_CR231","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.09.003","volume":"30","author":"S Softic","year":"2019","unstructured":"Softic S, Meyer JG, Wang GX, Gupta MK, Batista TM, Lauritzen H, Fujisaka S, Serra D, Herrero L, Willoughby J, Fitzgerald K, Ilkayeva O, Newgard CB, Gibson BW, Schilling B, Cohen DE, Kahn CR (2019) Dietary sugars alter hepatic fatty acid oxidation via transcriptional and post-translational modifications of mitochondrial proteins. Cell Metab 30(735\u2013753):e4. https:\/\/doi.org\/10.1016\/j.cmet.2019.09.003","journal-title":"Cell Metab"},{"key":"1410_CR232","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/hep.24283","volume":"53","author":"S Sookoian","year":"2011","unstructured":"Sookoian S, Pirola CJ (2011) Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 53:1883\u20131894. https:\/\/doi.org\/10.1002\/hep.24283","journal-title":"Hepatology"},{"key":"1410_CR233","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/jcm10010036","volume":"10","author":"P-A Soret","year":"2021","unstructured":"Soret P-A, Magusto J, Housset C, Gautheron J (2021) In vitro and in vivo models of non-alcoholic fatty liver disease: a critical appraisal. J Clin Med 10:36. https:\/\/doi.org\/10.3390\/jcm10010036","journal-title":"J Clin Med"},{"key":"1410_CR234","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/s41366-019-0363-7","volume":"43","author":"JR Speakman","year":"2019","unstructured":"Speakman JR (2019) Use of high-fat diets to study rodent obesity as a model of human obesity. Int J Obes (lond) 43:1491\u20131492. https:\/\/doi.org\/10.1038\/s41366-019-0363-7","journal-title":"Int J Obes (lond)"},{"key":"1410_CR235","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/hep.23122","volume":"50","author":"A Spruss","year":"2009","unstructured":"Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC, Bergheim I (2009) Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50:1094\u20131104. https:\/\/doi.org\/10.1002\/hep.23122","journal-title":"Hepatology"},{"key":"1410_CR236","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/hep.26461","volume":"58","author":"B Staels","year":"2013","unstructured":"Staels B, Rubenstrunk A, Noel B, Rigou G, Delataille P, Millatt LJ, Baron M, Lucas A, Tailleux A, Hum DW, Ratziu V, Cariou B, Hanf R (2013) Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Hepatology 58:1941\u20131952. https:\/\/doi.org\/10.1002\/hep.26461","journal-title":"Hepatology"},{"key":"1410_CR237","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/ijo.2014.187","volume":"39","author":"K Stemmer","year":"2015","unstructured":"Stemmer K, Kotzbeck P, Zani F, Bauer M, Neff C, M\u00fcller T, Pfluger P, Seeley R, Divanovic S (2015) Thermoneutral housing is a critical factor for immune function and diet-induced obesity in C57BL\/6 nude mice. Int J Obes 39:791\u2013797. https:\/\/doi.org\/10.1038\/ijo.2014.187","journal-title":"Int J Obes"},{"key":"1410_CR238","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12876-019-0958-4","volume":"19","author":"G Sun","year":"2019","unstructured":"Sun G, Jackson CV, Zimmerman K, Zhang LK, Finnearty CM, Sandusky GE, Zhang G, Peterson RG, Wang YJ (2019) The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. BMC Gastroenterol 19:41. https:\/\/doi.org\/10.1186\/s12876-019-0958-4","journal-title":"BMC Gastroenterol"},{"key":"1410_CR239","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/oby.22472","volume":"27","author":"G Sundborn","year":"2019","unstructured":"Sundborn G, Thornley S, Merriman TR, Lang B, King C, Lanaspa MA, Johnson RJ (2019) Are liquid sugars different from solid sugar in their ability to cause metabolic syndrome? Obesity 27:879\u2013887. https:\/\/doi.org\/10.1002\/oby.22472","journal-title":"Obesity"},{"key":"1410_CR240","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","volume":"17","author":"S Sutti","year":"2020","unstructured":"Sutti S, Albano E (2020) Adaptive immunity: an emerging player in the progression of NAFLD. Nat Rev Gastroenterol Hepatol 17:81\u201392. https:\/\/doi.org\/10.1038\/s41575-019-0210-2","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1410_CR241","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1586\/17474124.2016.1111758","volume":"10","author":"S Sutti","year":"2016","unstructured":"Sutti S, Bruzzi S, Albano E (2016) The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update. Expert Rev Gastroenterol Hepatol 10:243\u2013253. https:\/\/doi.org\/10.1586\/17474124.2016.1111758","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"1410_CR242","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1210\/en.2005-1209","volume":"147","author":"GM Sutton","year":"2006","unstructured":"Sutton GM, Trevaskis JL, Hulver MW, Mcmillan RP, Markward NJ, Babin MJ, Meyer EA, Butler AA (2006) Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL\/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology 147:2183\u20132196. https:\/\/doi.org\/10.1210\/en.2005-1209","journal-title":"Endocrinology"},{"key":"1410_CR243","doi-asserted-by":"publisher","first-page":"729","DOI":"10.21037\/atm-20-4354","volume":"9","author":"F Tacke","year":"2021","unstructured":"Tacke F, Weiskirchen R (2021) Non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention. Ann Transl Med 9:729. https:\/\/doi.org\/10.21037\/atm-20-4354","journal-title":"Ann Transl Med"},{"key":"1410_CR244","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168969","author":"M Tahri-Joutey","year":"2021","unstructured":"Tahri-Joutey M, Andreoletti P, Surapureddi S, Nasser B, Cherkaoui-Malki M, Latruffe N (2021) Mechanisms mediating the regulation of peroxisomal fatty acid beta-oxidation by PPAR\u03b1. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22168969","journal-title":"Int J Mol Sci"},{"key":"1410_CR245","doi-asserted-by":"publisher","first-page":"15539","DOI":"10.3748\/wjg.v20.i42.15539","volume":"20","author":"Y Takahashi","year":"2014","unstructured":"Takahashi Y, Fukusato T (2014) Histopathology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J Gastroenterol 20:15539\u201315548. https:\/\/doi.org\/10.3748\/wjg.v20.i42.15539","journal-title":"World J Gastroenterol"},{"key":"1410_CR246","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.3748\/wjg.v18.i19.2300","volume":"18","author":"Y Takahashi","year":"2012","unstructured":"Takahashi Y, Soejima Y, Fukusato T (2012) Animal models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J Gastroenterol 18:2300\u20132308. https:\/\/doi.org\/10.3748\/wjg.v18.i19.2300","journal-title":"World J Gastroenterol"},{"key":"1410_CR247","doi-asserted-by":"publisher","first-page":"15924","DOI":"10.1073\/pnas.0306981100","volume":"100","author":"T Tanaka","year":"2003","unstructured":"Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y, Watanabe M, Magoori K, Ioka RX, Tachibana K, Watanabe Y, Uchiyama Y, Sumi K, Iguchi H, Ito S, Doi T, Hamakubo T, Naito M, Auwerx J, Yanagisawa M, Kodama T, Sakai J (2003) Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 100:15924\u201315929. https:\/\/doi.org\/10.1073\/pnas.0306981100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1410_CR248","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1152\/physrev.00019.2009","volume":"90","author":"L Tappy","year":"2010","unstructured":"Tappy L, Le KA (2010) Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 90:23\u201346. https:\/\/doi.org\/10.1152\/physrev.00019.2009","journal-title":"Physiol Rev"},{"key":"1410_CR249","doi-asserted-by":"publisher","first-page":"G987","DOI":"10.1152\/ajpgi.90272.2008","volume":"295","author":"LH Tetri","year":"2008","unstructured":"Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander-Tetri BA (2008) Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 295:G987\u2013G995. https:\/\/doi.org\/10.1152\/ajpgi.90272.2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1410_CR250","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3748\/wjg.v24.i2.179","volume":"24","author":"KS Tolbol","year":"2018","unstructured":"Tolbol KS, Kristiansen MN, Hansen HH, Veidal SS, Rigbolt KT, Gillum MP, Jelsing J, Vrang N, Feigh M (2018) Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis. World J Gastroenterol 24:179\u2013194. https:\/\/doi.org\/10.3748\/wjg.v24.i2.179","journal-title":"World J Gastroenterol"},{"key":"1410_CR251","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41419-019-1458-8","volume":"10","author":"L Tong","year":"2019","unstructured":"Tong L, Wang L, Yao S, Jin L, Yang J, Zhang Y, Ning G, Zhang Z (2019) PPAR\u03b4 attenuates hepatic steatosis through autophagy-mediated fatty acid oxidation. Cell Death Dis 10:197. https:\/\/doi.org\/10.1038\/s41419-019-1458-8","journal-title":"Cell Death Dis"},{"key":"1410_CR252","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","volume":"77","author":"P Tontonoz","year":"2008","unstructured":"Tontonoz P, Spiegelman BM (2008) Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem 77:289\u2013312. https:\/\/doi.org\/10.1146\/annurev.biochem.77.061307.091829","journal-title":"Annu Rev Biochem"},{"key":"1410_CR253","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083481","volume":"8","author":"PG Traber","year":"2013","unstructured":"Traber PG, Zomer E (2013) Therapy of experimental NASH and fibrosis with galectin inhibitors. PLoS ONE 8:e83481. https:\/\/doi.org\/10.1371\/journal.pone.0083481","journal-title":"PLoS ONE"},{"key":"1410_CR254","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","volume":"69","author":"T Tsuchida","year":"2018","unstructured":"Tsuchida T, Lee YA, Fujiwara N, Ybanez M, Allen B, Martins S, Fiel MI, Goossens N, Chou H-I, Hoshida Y (2018) A simple diet-and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. J Hepatol 69:385\u2013395. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.011","journal-title":"J Hepatol"},{"key":"1410_CR255","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.1108750","volume":"308","author":"FW Turek","year":"2005","unstructured":"Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, Mcdearmon E, Laposky A, Losee-Olson S, Easton A, Jensen DR (2005a) Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308:1043\u20131045","journal-title":"Science"},{"key":"1410_CR256","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.1108750","volume":"308","author":"FW Turek","year":"2005","unstructured":"Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, Mcdearmon E, Laposky A, Losee-Olson S, Easton A, Jensen DR, Eckel RH, Takahashi JS, Bass J (2005b) Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308:1043\u20131045. https:\/\/doi.org\/10.1126\/science.1108750","journal-title":"Science"},{"key":"1410_CR257","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn0050","author":"CM Upchurch","year":"2022","unstructured":"Upchurch CM, Yeudall S, Pavelec CM, Merk D, Greulich J, Manjegowda M, Raghavan SS, Bochkis IM, Scott MM, Perez-Reyes E, Leitinger N (2022) Targeting oxidized phospholipids by AAV-based gene therapy in mice with established hepatic steatosis prevents progression to fibrosis. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abn0050","journal-title":"Sci Adv"},{"key":"1410_CR258","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1111\/j.1572-0241.2000.03297.x","volume":"95","author":"A Uygun","year":"2000","unstructured":"Uygun A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M, Deveci MS, Bagci S, Gulsen M, Karaeren N, Dagalp K (2000) Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 95:3584\u20133589. https:\/\/doi.org\/10.1111\/j.1572-0241.2000.03297.x","journal-title":"Am J Gastroenterol"},{"key":"1410_CR259","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1172\/JCI9238","volume":"106","author":"C Vaisse","year":"2000","unstructured":"Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P (2000) Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 106:253\u2013262. https:\/\/doi.org\/10.1172\/JCI9238","journal-title":"J Clin Invest"},{"key":"1410_CR260","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/hep.23622","volume":"51","author":"L Valenti","year":"2010","unstructured":"Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, Dongiovanni P, Nobili V, Mozzi E, Roviaro G, Vanni E, Bugianesi E, Maggioni M, Fracanzani AL, Fargion S, Day CP (2010a) Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 51:1209\u20131217. https:\/\/doi.org\/10.1002\/hep.23622","journal-title":"Hepatology"},{"key":"1410_CR261","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/hep.23823","volume":"52","author":"L Valenti","year":"2010","unstructured":"Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, Dongiovanni P, Fargion S, Nobili V (2010b) I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 52:1274\u20131280. https:\/\/doi.org\/10.1002\/hep.23823","journal-title":"Hepatology"},{"key":"1410_CR262","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.25617","volume":"55","author":"L Valenti","year":"2012","unstructured":"Valenti L, Alisi A, Nobili V (2012) Unraveling the genetics of fatty liver in obese children: additive effect of P446L GCKR and I148M PNPLA3 polymorphisms. Hepatology 55:661\u2013663. https:\/\/doi.org\/10.1002\/hep.25617","journal-title":"Hepatology"},{"key":"1410_CR263","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3390\/cells9092014","volume":"9","author":"AM Van Den Hoek","year":"2020","unstructured":"Van Den Hoek AM, Verschuren L, Worms N, Van Nieuwkoop A, De Ruiter C, Attema J, Menke AL, Caspers MP, Radhakrishnan S, Salic K (2020) A translational mouse model for NASH with advanced fibrosis and atherosclerosis expressing key pathways of human pathology. Cells 9:2014","journal-title":"Cells"},{"key":"1410_CR264","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3390\/nu9101072","volume":"9","author":"MA Van Herck","year":"2017","unstructured":"Van Herck MA, Vonghia L, Francque SM (2017) Animal models of nonalcoholic fatty liver disease-a starter\u2019s guide. Nutrients 9:1072. https:\/\/doi.org\/10.3390\/nu9101072","journal-title":"Nutrients"},{"key":"1410_CR265","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jhep.2013.02.024","volume":"59","author":"DM Van Rooyen","year":"2013","unstructured":"Van Rooyen DM, Gan LT, Yeh MM, Haigh WG, Larter CZ, Ioannou G, Teoh NC, Farrell GC (2013) Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome. J Hepatol 59:144\u2013152. https:\/\/doi.org\/10.1016\/j.jhep.2013.02.024","journal-title":"J Hepatol"},{"key":"1410_CR266","doi-asserted-by":"publisher","first-page":"42774","DOI":"10.1074\/jbc.M306022200","volume":"278","author":"L Vergnes","year":"2003","unstructured":"Vergnes L, Phan J, Strauss M, Tafuri S, Reue K (2003) Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J Biol Chem 278:42774\u201342784. https:\/\/doi.org\/10.1074\/jbc.M306022200","journal-title":"J Biol Chem"},{"key":"1410_CR267","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.tem.2012.05.001","volume":"23","author":"W Wahli","year":"2012","unstructured":"Wahli W, Michalik L (2012) PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol Metab 23:351\u2013363. https:\/\/doi.org\/10.1016\/j.tem.2012.05.001","journal-title":"Trends Endocrinol Metab"},{"key":"1410_CR268","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1038\/onc.2009.468","volume":"29","author":"B Wang","year":"2010","unstructured":"Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshal K (2010) TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 29:1787\u20131797. https:\/\/doi.org\/10.1038\/onc.2009.468","journal-title":"Oncogene"},{"key":"1410_CR269","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2174\/1573399810666140508121012","volume":"10","author":"B Wang","year":"2014","unstructured":"Wang B, Chandrasekera PC, Pippin JJ (2014) Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Curr Diabetes Rev 10:131\u2013145. https:\/\/doi.org\/10.2174\/1573399810666140508121012","journal-title":"Curr Diabetes Rev"},{"key":"1410_CR270","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","volume":"24","author":"X Wang","year":"2016","unstructured":"Wang X, Zheng Z, Caviglia JM, Corey KE, Herfel TM, Cai B, Masia R, Chung RT, Lefkowitch JH, Schwabe RF, Tabas I (2016) Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis. Cell Metab 24:848\u2013862. https:\/\/doi.org\/10.1016\/j.cmet.2016.09.016","journal-title":"Cell Metab"},{"key":"1410_CR271","doi-asserted-by":"publisher","first-page":"13999","DOI":"10.1038\/s41598-017-14376-y","volume":"7","author":"ME Wang","year":"2017","unstructured":"Wang ME, Singh BK, Hsu MC, Huang C, Yen PM, Wu LS, Jong DS, Chiu CH (2017) Increasing dietary medium-chain fatty acid ratio mitigates high-fat diet-induced non-alcoholic steatohepatitis by regulating autophagy. Sci Rep 7:13999. https:\/\/doi.org\/10.1038\/s41598-017-14376-y","journal-title":"Sci Rep"},{"key":"1410_CR272","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.jhep.2021.11.031","volume":"76","author":"X Wang","year":"2022","unstructured":"Wang X, Zeldin S, Shi H, Zhu C, Saito Y, Corey KE, Osganian SA, Remotti HE, Verna EC, Pajvani UB, Schwabe RF, Tabas I (2022) TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis. J Hepatol 76:910\u2013920. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.031","journal-title":"J Hepatol"},{"key":"1410_CR273","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1172\/jci21025","volume":"113","author":"M Watanabe","year":"2004","unstructured":"Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, Moore DD, Auwerx J (2004) Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 113:1408\u20131418. https:\/\/doi.org\/10.1172\/jci21025","journal-title":"J Clin Invest"},{"key":"1410_CR274","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/hep4.1057","volume":"1","author":"G Wettstein","year":"2017","unstructured":"Wettstein G, Luccarini JM, Poekes L, Faye P, Kupkowski F, Adarbes V, Defrene E, Estivalet C, Gawronski X, Jantzen I, Philippot A, Tessier J, Tuyaa-Boustugue P, Oakley F, Mann DA, Leclercq I, Francque S, Konstantinova I, Broqua P, Junien JL (2017) The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis. Hepatol Commun 1:524\u2013537. https:\/\/doi.org\/10.1002\/hep4.1057","journal-title":"Hepatol Commun"},{"key":"1410_CR275","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","volume":"26","author":"MJ Wolf","year":"2014","unstructured":"Wolf MJ, Adili A, Piotrowitz K, Abdullah Z, Boege Y, Stemmer K, Ringelhan M, Simonavicius N, Egger M, Wohlleber D, Lorentzen A, Einer C, Schulz S, Clavel T, Protzer U, Thiele C, Zischka H, Moch H, Tschop M, Tumanov AV, Haller D, Unger K, Karin M, Kopf M, Knolle P, Weber A, Heikenwalder M (2014) Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes. Cancer Cell 26:549\u2013564. https:\/\/doi.org\/10.1016\/j.ccell.2014.09.003","journal-title":"Cancer Cell"},{"key":"1410_CR276","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s10620-007-0193-7","volume":"53","author":"M Wortham","year":"2008","unstructured":"Wortham M, He L, Gyamfi M, Copple BL, Wan YJ (2008) The transition from fatty liver to NASH associates with SAMe depletion in db\/db mice fed a methionine choline-deficient diet. Dig Dis Sci 53:2761\u20132774. https:\/\/doi.org\/10.1007\/s10620-007-0193-7","journal-title":"Dig Dis Sci"},{"key":"1410_CR277","doi-asserted-by":"publisher","first-page":"42762","DOI":"10.18632\/oncotarget.8641","volume":"7","author":"J Wu","year":"2016","unstructured":"Wu J (2016) Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma. Oncotarget 7:42762\u201342776. https:\/\/doi.org\/10.18632\/oncotarget.8641","journal-title":"Oncotarget"},{"key":"1410_CR278","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ijbiomac.2018.09.151","volume":"120","author":"J Xiao","year":"2018","unstructured":"Xiao J, Wang F, Liong EC, So KF, Tipoe GL (2018) Lycium barbarum polysaccharides improve hepatic injury through NFkappa-B and NLRP3\/6 pathways in a methionine choline deficient diet steatohepatitis mouse model. Int J Biol Macromol 120:1480\u20131489. https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.09.151","journal-title":"Int J Biol Macromol"},{"key":"1410_CR279","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.21655","volume":"45","author":"K Yamaguchi","year":"2007","unstructured":"Yamaguchi K, Yang L, Mccall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM (2007) Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45:1366\u20131374. https:\/\/doi.org\/10.1002\/hep.21655","journal-title":"Hepatology"},{"key":"1410_CR280","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1440-1746.2007.05150.x","volume":"23","author":"Y Yamazaki","year":"2008","unstructured":"Yamazaki Y, Kakizaki S, Takizawa D, Ichikawa T, Sato K, Takagi H, Mori M (2008) Interstrain differences in susceptibility to non-alcoholic steatohepatitis. J Gastroenterol Hepatol 23:276\u2013282. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.05150.x","journal-title":"J Gastroenterol Hepatol"},{"key":"1410_CR281","doi-asserted-by":"publisher","first-page":"536","DOI":"10.5483\/bmbrep.2016.49.10.144","volume":"49","author":"JY Yang","year":"2016","unstructured":"Yang JY, Kweon MN (2016) The gut microbiota: a key regulator of metabolic diseases. BMB Rep 49:536\u2013541. https:\/\/doi.org\/10.5483\/bmbrep.2016.49.10.144","journal-title":"BMB Rep"},{"key":"1410_CR282","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s12072-010-9202-6","volume":"4","author":"ZX Yang","year":"2010","unstructured":"Yang ZX, Shen W, Sun H (2010) Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease. Hepatol Int 4:741\u2013748. https:\/\/doi.org\/10.1007\/s12072-010-9202-6","journal-title":"Hepatol Int"},{"key":"1410_CR283","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1139\/o90-079","volume":"68","author":"ZM Yao","year":"1990","unstructured":"Yao ZM, Vance DE (1990) Reduction in VLDL, but not HDL, in plasma of rats deficient in choline. Biochem Cell Biol 68:552\u2013558. https:\/\/doi.org\/10.1139\/o90-079","journal-title":"Biochem Cell Biol"},{"key":"1410_CR284","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.mpdhp.2008.09.005","volume":"14","author":"MM Yeh","year":"2008","unstructured":"Yeh MM, Brunt EM (2008) Pathology of fatty liver: differential diagnosis of non-alcoholic fatty liver disease. Diagn Histopathol 14:586\u2013597. https:\/\/doi.org\/10.1016\/j.mpdhp.2008.09.005","journal-title":"Diagn Histopathol"},{"key":"1410_CR285","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1152\/physrev.2001.81.3.1097","volume":"81","author":"PM Yen","year":"2001","unstructured":"Yen PM (2001) Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097\u20131142. https:\/\/doi.org\/10.1152\/physrev.2001.81.3.1097","journal-title":"Physiol Rev"},{"key":"1410_CR286","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/j.1365-2036.2012.05080.x","volume":"35","author":"Y Yilmaz","year":"2012","unstructured":"Yilmaz Y (2012) Review article: fructose in non-alcoholic fatty liver disease. Aliment Pharmacol Ther 35:1135\u20131144. https:\/\/doi.org\/10.1111\/j.1365-2036.2012.05080.x","journal-title":"Aliment Pharmacol Ther"},{"key":"1410_CR287","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E (2018) Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15:11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"748\u2013755","key":"1410_CR288","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.05.057","volume":"17","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Stepanova M, Ong JP, Jacobson IM, Bugianesi E, Duseja A, Eguchi Y, Wong VW, Negro F, Yilmaz Y (2019a) Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol 17(748\u2013755):e3. https:\/\/doi.org\/10.1016\/j.cgh.2018.05.057","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1410_CR289","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","volume":"394","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, Macconell L, Shringarpure R, Harrison S, Sanyal AJ, Investigators RS (2019b) Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 394:2184\u20132196. https:\/\/doi.org\/10.1016\/S0140-6736(19)33041-7","journal-title":"Lancet"},{"key":"1410_CR290","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.cmet.2014.11.008","volume":"20","author":"A Zarrinpar","year":"2014","unstructured":"Zarrinpar A, Chaix A, Yooseph S, Panda S (2014) Diet and feeding pattern affect the diurnal dynamics of the gut microbiome. Cell Metab 20:1006\u20131017. https:\/\/doi.org\/10.1016\/j.cmet.2014.11.008","journal-title":"Cell Metab"},{"key":"1410_CR291","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-042843","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wu M, Liu Z, Yuan H, Wu X, Shi T, Chen X, Zhang T (2021) Increasing prevalence of NAFLD\/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study. BMJ Open 11:e042843. https:\/\/doi.org\/10.1136\/bmjopen-2020-042843","journal-title":"BMJ Open"},{"key":"1410_CR292","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119403","volume":"276","author":"J Zhou","year":"2021","unstructured":"Zhou J, Zhao Y, Guo YJ, Zhao YS, Liu H, Ren J, Li JR, Ji ES (2021) A rapid juvenile murine model of nonalcoholic steatohepatitis (NASH): Chronic intermittent hypoxia exacerbates Western diet-induced NASH. Life Sci 276:119403. https:\/\/doi.org\/10.1016\/j.lfs.2021.119403","journal-title":"Life Sci"},{"key":"1410_CR293","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1089\/thy.2021.0621","volume":"32","author":"J Zhou","year":"2022","unstructured":"Zhou J, Tripathi M, Ho JP, Widjaja AA, Shekeran SG, Camat MD, James A, Wu Y, Ching J, Kovalik JP, Lim KH, Cook SA, Bay BH, Singh BK, Yen PM (2022) Thyroid hormone decreases hepatic steatosis, inflammation, and fibrosis in a dietary mouse model of nonalcoholic steatohepatitis. Thyroid 32:725\u2013738. https:\/\/doi.org\/10.1089\/thy.2021.0621","journal-title":"Thyroid"},{"key":"1410_CR294","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","volume":"57","author":"L Zhu","year":"2013","unstructured":"Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, Gill SR (2013) Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57:601\u2013609. https:\/\/doi.org\/10.1002\/hep.26093","journal-title":"Hepatology"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-022-01410-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-022-01410-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-022-01410-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T22:26:16Z","timestamp":1669501576000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-022-01410-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":294,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1410"],"URL":"https:\/\/doi.org\/10.1007\/s12272-022-01410-5","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"2 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}